| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5M10 GPR17 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 TAAR2 GPR55 OR2J3 OR2J2 GPR183 LTB4R2 GRM1 GRM5 OR1J4 OR1L3 OR6P1 OR1L1 PTH2R OPRD1 OPRK1 OPRL1 OPRM1 FZD4 OR10G6 OR1L8 FZD9 OR8A1 TAS2R1 PROKR2 OR10G2 CXCR6 LPAR6 APLNR OR1L6 OR1G1 P2RY10 CCR8 ACKR2 FZD2 OR1L4 | 4.08e-20 | 884 | 171 | 42 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | IL10RB IL12RB1 FLT1 ERBB3 OR5M10 GPR17 OR9A4 OR5M1 OR1S1 OR1S2 L1CAM OR2G3 TAAR2 GPR55 OR2J3 OR2J2 GPR183 LTB4R2 GRM1 GRM5 OR1J4 OR1L3 OR6P1 OR1L1 PTH2R OPRD1 OPRK1 OPRL1 OPRM1 FZD4 OR10G6 OR1L8 FZD9 OR8A1 TAS2R1 IGF1R IL22RA2 PROKR2 OR10G2 CXCR6 LPAR6 APLNR OR1L6 OR1G1 P2RY10 TRPV4 CCR8 ACKR2 FZD2 EPHA3 OR1L4 | 4.10e-20 | 1353 | 171 | 51 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 OR10G2 OR1L6 OR1G1 OR1L4 | 5.77e-09 | 431 | 171 | 19 | GO:0004984 |
| GeneOntologyMolecularFunction | transporter activity | TMEM144 SLC25A21 SLC31A1 SLC35D2 CACNA2D2 ASIC2 SLC38A4 ATG2B SLC44A2 ATP13A5 ATP5MF SLCO1B1 ATP13A2 ANKH SLC16A12 OPRM1 TPCN1 SLC35D1 SLC6A4 SLC6A8 PIEZO2 IGF1R GJE1 SLC24A2 SLC20A1 SCN4A MPC1 SLC36A3 TRPV4 CACNA1I ATP13A3 TMC5 SLC12A7 | 1.25e-08 | 1289 | 171 | 33 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TMEM144 SLC25A21 SLC31A1 SLC35D2 CACNA2D2 ASIC2 SLC38A4 SLC44A2 ATP13A5 ATP5MF SLCO1B1 ATP13A2 ANKH SLC16A12 OPRM1 TPCN1 SLC35D1 SLC6A4 SLC6A8 PIEZO2 GJE1 SLC24A2 SLC20A1 SCN4A MPC1 SLC36A3 TRPV4 CACNA1I ATP13A3 TMC5 SLC12A7 | 2.08e-08 | 1180 | 171 | 31 | GO:0022857 |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 1.78e-07 | 7 | 171 | 4 | GO:0004985 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC25A21 SLC35D2 SLC38A4 SLC44A2 SLCO1B1 ANKH SLC16A12 SLC35D1 SLC6A4 SLC6A8 SLC24A2 SLC20A1 SLC36A3 SLC12A7 | 2.75e-07 | 296 | 171 | 14 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC25A21 SLC35D2 SLC38A4 SLC44A2 ATP13A5 SLCO1B1 ATP13A2 ANKH SLC16A12 SLC35D1 SLC6A4 SLC6A8 SLC24A2 SLC20A1 SLC36A3 ATP13A3 SLC12A7 | 7.77e-07 | 477 | 171 | 17 | GO:0022804 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC31A1 CACNA2D2 ASIC2 SLC38A4 ATP13A5 ATP5MF ATP13A2 OPRM1 TPCN1 SLC6A4 SLC6A8 PIEZO2 SLC24A2 SLC20A1 SCN4A SLC36A3 TRPV4 CACNA1I ATP13A3 SLC12A7 | 1.11e-06 | 664 | 171 | 20 | GO:0008324 |
| GeneOntologyMolecularFunction | cytokine receptor activity | 1.86e-06 | 97 | 171 | 8 | GO:0004896 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC31A1 CACNA2D2 ASIC2 SLC38A4 ATP13A5 ATP5MF ATP13A2 OPRM1 TPCN1 SLC6A4 SLC6A8 PIEZO2 SLC24A2 SLC20A1 SCN4A SLC36A3 TRPV4 CACNA1I ATP13A3 TMC5 SLC12A7 | 4.48e-06 | 793 | 171 | 21 | GO:0015075 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | ASIC2 SLC38A4 TPCN1 SLC6A4 SLC6A8 SLC24A2 SLC20A1 SCN4A CACNA1I | 1.70e-05 | 171 | 171 | 9 | GO:0015081 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.94e-05 | 133 | 171 | 8 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.81e-05 | 140 | 171 | 8 | GO:0001653 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC31A1 CACNA2D2 ASIC2 SLC38A4 OPRM1 TPCN1 SLC6A4 SLC6A8 SLC24A2 SLC20A1 SCN4A TRPV4 CACNA1I SLC12A7 | 4.94e-05 | 465 | 171 | 14 | GO:0046873 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 5.61e-05 | 199 | 171 | 9 | GO:1901981 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 6.70e-05 | 26 | 171 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 6.70e-05 | 26 | 171 | 4 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 6.70e-05 | 26 | 171 | 4 | GO:0004950 | |
| GeneOntologyMolecularFunction | ABC-type polyamine transporter activity | 7.29e-05 | 2 | 171 | 2 | GO:0015417 | |
| GeneOntologyMolecularFunction | UDP-glucuronic acid transmembrane transporter activity | 7.29e-05 | 2 | 171 | 2 | GO:0005461 | |
| GeneOntologyMolecularFunction | UDP-N-acetylgalactosamine transmembrane transporter activity | 7.29e-05 | 2 | 171 | 2 | GO:0005463 | |
| GeneOntologyMolecularFunction | PLC activating G protein-coupled glutamate receptor activity | 7.29e-05 | 2 | 171 | 2 | GO:0001639 | |
| GeneOntologyMolecularFunction | immune receptor activity | 9.01e-05 | 165 | 171 | 8 | GO:0140375 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 9.68e-05 | 11 | 171 | 3 | GO:0015203 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC31A1 CACNA2D2 ASIC2 SLC38A4 ATP5MF OPRM1 TPCN1 SLC6A4 SLC6A8 SLC24A2 SLC20A1 SCN4A SLC36A3 TRPV4 CACNA1I SLC12A7 | 1.01e-04 | 627 | 171 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | channel activity | CACNA2D2 ASIC2 ATP5MF OPRM1 TPCN1 SLC6A4 PIEZO2 GJE1 SLC24A2 SCN4A TRPV4 CACNA1I TMC5 SLC12A7 | 1.77e-04 | 525 | 171 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA2D2 ASIC2 ATP5MF OPRM1 TPCN1 SLC6A4 PIEZO2 GJE1 SLC24A2 SCN4A TRPV4 CACNA1I TMC5 SLC12A7 | 1.81e-04 | 526 | 171 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA2D2 ASIC2 ATP5MF OPRM1 TPCN1 SLC6A4 PIEZO2 SLC24A2 SCN4A TRPV4 CACNA1I | 1.88e-04 | 343 | 171 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | KDEL sequence binding | 2.18e-04 | 3 | 171 | 2 | GO:0005046 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC25A21 SLC35D2 SLC38A4 SLCO1B1 ANKH SLC16A12 SLC35D1 SLC6A8 MPC1 SLC36A3 | 2.24e-04 | 293 | 171 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.75e-04 | 37 | 171 | 4 | GO:0042923 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC38A4 ATP13A5 ATP13A2 SLC6A4 SLC6A8 SLC24A2 SLC20A1 SLC36A3 ATP13A3 SLC12A7 | 2.78e-04 | 301 | 171 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC31A1 CACNA2D2 ASIC2 SLC38A4 ATP5MF ANKH OPRM1 TPCN1 SLC6A4 SLC6A8 SLC24A2 SLC20A1 SCN4A SLC36A3 TRPV4 CACNA1I SLC12A7 | 2.85e-04 | 758 | 171 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | symporter activity | 3.15e-04 | 150 | 171 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 3.84e-04 | 17 | 171 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | DPEP1 RAG2 IQGAP2 ATG2B ATP13A2 TPCN1 CADPS BTK SNX27 ZFYVE26 | 4.09e-04 | 316 | 171 | 10 | GO:0035091 |
| GeneOntologyMolecularFunction | creatine transmembrane transporter activity | 4.33e-04 | 4 | 171 | 2 | GO:0005308 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 4.33e-04 | 4 | 171 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 4.58e-04 | 18 | 171 | 3 | GO:0008381 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.64e-04 | 119 | 171 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA2D2 ASIC2 ATP5MF OPRM1 TPCN1 SLC6A4 PIEZO2 SLC24A2 SCN4A TRPV4 CACNA1I TMC5 | 6.15e-04 | 459 | 171 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | UDP-N-acetylglucosamine transmembrane transporter activity | 7.17e-04 | 5 | 171 | 2 | GO:0005462 | |
| GeneOntologyMolecularFunction | ER retention sequence binding | 7.17e-04 | 5 | 171 | 2 | GO:0046923 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential | 7.17e-04 | 5 | 171 | 2 | GO:0099530 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 7.36e-04 | 83 | 171 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | calcium channel activity | 8.62e-04 | 129 | 171 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 9.63e-04 | 23 | 171 | 3 | GO:0016493 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 9.63e-04 | 23 | 171 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.02e-03 | 52 | 171 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 1.09e-03 | 24 | 171 | 3 | GO:0019957 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.22e-03 | 138 | 171 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.39e-03 | 26 | 171 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.91e-03 | 29 | 171 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.93e-03 | 151 | 171 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 1.97e-03 | 8 | 171 | 2 | GO:0015220 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.08e-03 | 207 | 171 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.14e-03 | 208 | 171 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate binding | 2.33e-03 | 31 | 171 | 3 | GO:0080025 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.34e-03 | 65 | 171 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | cytokine binding | 2.35e-03 | 157 | 171 | 6 | GO:0019955 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 2.52e-03 | 9 | 171 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 2.52e-03 | 9 | 171 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | phospholipid binding | DPEP1 RAG2 IQGAP2 ANXA1 ATG2B DYSF ATP13A2 TPCN1 CADPS BTK SNX27 ZFYVE26 | 2.75e-03 | 548 | 171 | 12 | GO:0005543 |
| GeneOntologyMolecularFunction | chemokine binding | 2.79e-03 | 33 | 171 | 3 | GO:0019956 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 3.04e-03 | 34 | 171 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | receptor serine/threonine kinase binding | 3.30e-03 | 35 | 171 | 3 | GO:0033612 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 3.58e-03 | 36 | 171 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 3.58e-03 | 36 | 171 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 3.81e-03 | 11 | 171 | 2 | GO:0015165 | |
| GeneOntologyMolecularFunction | lipid binding | DPEP1 RAG2 IQGAP2 ANXA1 TMEM199 ATG2B GPR183 DYSF ATP13A2 TPCN1 SH3GLB1 CADPS BTK SNX27 TRPV4 ZFYVE26 CADPS2 | 4.90e-03 | 988 | 171 | 17 | GO:0008289 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 5.18e-03 | 81 | 171 | 4 | GO:0015370 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5M10 GPR17 OR9A4 OR5M1 IQGAP2 ANXA1 OR1S1 OR1S2 OR2G3 TAAR2 GPR55 OR2J3 OR2J2 GPR183 CAV2 LTB4R2 GRM1 GRM5 OR1J4 OR1L3 OR6P1 OR1L1 PTH2R OPRD1 OPRK1 OPRL1 OPRM1 FZD4 OR10G6 OR1L8 FZD9 OR8A1 TAS2R1 PROKR2 OR10G2 CXCR6 LPAR6 APLNR OR1L6 OR1G1 P2RY10 CCR8 ACKR2 FZD2 OR1L4 | 1.91e-15 | 1395 | 173 | 45 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5M10 OR9A4 OR5M1 ASIC2 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 TAS2R1 OR10G2 OR1L6 OR1G1 UBR3 FZD2 OR1L4 | 2.16e-10 | 547 | 173 | 23 | GO:0007606 |
| GeneOntologyBiologicalProcess | sensory perception | OR5M10 OR9A4 OR5M1 ASIC2 WFS1 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 GRM1 OR1J4 CDC14A OR1L3 OR6P1 OR1L1 OPRK1 OPRL1 OPRM1 FZD4 IFNG OR10G6 OR1L8 OR8A1 TAS2R1 PIEZO2 OR10G2 OR1L6 OR1G1 UBR3 FZD2 OR1L4 | 3.22e-10 | 1072 | 173 | 32 | GO:0007600 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 OR10G2 OR1L6 OR1G1 UBR3 FZD2 OR1L4 | 3.88e-10 | 465 | 173 | 21 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5M10 OR9A4 OR5M1 ASIC2 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 TAS2R1 PIEZO2 OR10G2 OR1L6 OR1G1 OR1L4 | 3.95e-09 | 582 | 173 | 22 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 OR10G2 OR1L6 OR1G1 OR1L4 | 4.33e-09 | 432 | 173 | 19 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 TAS2R1 OR10G2 OR1L6 OR1G1 OR1L4 | 4.95e-09 | 485 | 173 | 20 | GO:0050907 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | KLHL24 SLC31A1 CACNA2D2 ASIC2 SLC38A4 ATP13A5 ATP5MF DYSF SELENON ATP13A2 OPRK1 OPRM1 TPCN1 IFNG SLC6A4 SLC6A8 PIEZO2 SLC24A2 SLC20A1 SCN4A APLNR UBR3 SLC36A3 TRPV4 CACNA1I ATP13A3 SLC12A7 AP3D1 | 5.31e-09 | 942 | 173 | 28 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | KLHL24 SLC31A1 CACNA2D2 ASIC2 WFS1 SLC38A4 ATP13A5 ATP5MF DYSF SELENON ATP13A2 OPRD1 OPRK1 OPRM1 TPCN1 IFNG SLC6A4 SLC6A8 PIEZO2 SLC24A2 SLC20A1 SCN4A APLNR UBR3 SLC36A3 TRPV4 CACNA1I ATP13A3 SLC12A7 NOS3 AP3D1 | 8.32e-09 | 1157 | 173 | 31 | GO:0006812 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 TAS2R1 OR10G2 OR1L6 OR1G1 OR1L4 | 1.81e-08 | 524 | 173 | 20 | GO:0009593 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | KLHL24 SLC31A1 CACNA2D2 ASIC2 WFS1 SLC38A4 ATP13A5 ATP5MF DYSF SELENON SLCO1B1 ATP13A2 OPRD1 OPRK1 OPRM1 TPCN1 IFNG SLC6A4 SLC6A8 PIEZO2 SLC24A2 SLC20A1 SCN4A APLNR UBR3 SLC36A3 TRPV4 CACNA1I ATP13A3 TMC5 SLC12A7 NOS3 AP3D1 | 3.61e-08 | 1374 | 173 | 33 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | KLHL24 SLC31A1 CACNA2D2 ASIC2 SLC38A4 ATP13A5 ATP5MF DYSF SELENON ATP13A2 OPRK1 OPRM1 TPCN1 IFNG SLC6A4 SLC6A8 PIEZO2 SLC24A2 SLC20A1 SCN4A APLNR UBR3 SLC36A3 TRPV4 CACNA1I ATP13A3 TMC5 SLC12A7 AP3D1 | 5.16e-08 | 1115 | 173 | 29 | GO:0034220 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5M10 OR9A4 OR5M1 ASIC2 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 TAS2R1 PIEZO2 OR10G2 OR1L6 OR1G1 OR1L4 | 1.79e-07 | 722 | 173 | 22 | GO:0051606 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 1.84e-07 | 133 | 173 | 10 | GO:0007200 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | KLHL24 SLC31A1 CACNA2D2 ASIC2 SLC38A4 ATP5MF DYSF SELENON OPRK1 OPRM1 TPCN1 IFNG SLC6A4 SLC6A8 SLC24A2 SLC20A1 SCN4A APLNR UBR3 SLC36A3 TRPV4 CACNA1I SLC12A7 AP3D1 | 8.28e-07 | 922 | 173 | 24 | GO:0098662 |
| GeneOntologyBiologicalProcess | metal ion transport | KLHL24 SLC31A1 CACNA2D2 ASIC2 WFS1 SLC38A4 DYSF SELENON OPRD1 OPRK1 OPRM1 TPCN1 IFNG SLC6A4 SLC6A8 SLC24A2 SLC20A1 SCN4A APLNR UBR3 TRPV4 CACNA1I SLC12A7 NOS3 AP3D1 | 9.97e-07 | 1000 | 173 | 25 | GO:0030001 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | SLC25A21 SLC35D2 SLC38A4 GRM1 SELENON SLC16A12 SLC35D1 SLC6A8 MPC1 SLC36A3 | 1.21e-06 | 163 | 173 | 10 | GO:1905039 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | KLHL24 SLC31A1 CACNA2D2 ASIC2 SLC38A4 ATP5MF DYSF SELENON ANKH OPRK1 OPRM1 TPCN1 IFNG SLC6A4 SLC6A8 SLC24A2 SLC20A1 SCN4A APLNR UBR3 SLC36A3 TRPV4 CACNA1I SLC12A7 AP3D1 | 1.35e-06 | 1017 | 173 | 25 | GO:0098660 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | SLC25A21 SLC35D2 SLC38A4 GRM1 SELENON SLC16A12 SLC35D1 SLC6A8 MPC1 SLC36A3 | 1.51e-06 | 167 | 173 | 10 | GO:1903825 |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 3.22e-06 | 13 | 173 | 4 | GO:0038003 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | SLC31A1 WFS1 TMEM199 ATP13A5 CAV2 GRM1 GRM5 SELENON ATP13A2 ANKH IFNG FZD9 SLC24A2 APLNR CORIN TRPV4 ATP13A3 SLC12A7 | 5.20e-06 | 622 | 173 | 18 | GO:0098771 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | KLHL24 ASIC2 SLC38A4 TPCN1 SLC6A4 SLC6A8 SLC24A2 SLC20A1 SCN4A CACNA1I | 1.07e-05 | 208 | 173 | 10 | GO:0035725 |
| GeneOntologyBiologicalProcess | conditioned place preference | 1.14e-05 | 6 | 173 | 3 | GO:1990708 | |
| GeneOntologyBiologicalProcess | sodium ion transport | KLHL24 ASIC2 SLC38A4 TPCN1 SLC6A4 SLC6A8 SLC24A2 SLC20A1 SCN4A CACNA1I NOS3 | 2.17e-05 | 275 | 173 | 11 | GO:0006814 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | WFS1 ATP13A5 CAV2 GRM1 GRM5 SELENON ATP13A2 ANKH FZD9 SLC24A2 APLNR TRPV4 ATP13A3 | 2.59e-05 | 389 | 173 | 13 | GO:0055074 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | SLC31A1 WFS1 TMEM199 ATP13A5 CAV2 GRM1 GRM5 SELENON ATP13A2 ANKH IFNG FZD9 SLC24A2 APLNR CORIN TRPV4 ATP13A3 SLC12A7 | 2.80e-05 | 705 | 173 | 18 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SLC31A1 WFS1 TMEM199 ATP13A5 CAV2 GRM1 GRM5 SELENON ATP13A2 ANKH IFNG FZD9 SLC24A2 APLNR CORIN TRPV4 ATP13A3 SLC12A7 | 3.49e-05 | 717 | 173 | 18 | GO:0050801 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CACNA2D2 ASIC2 L1CAM ANKS1B ALS2 CAV2 GRM1 EZH2 DYSF GRM5 OPRK1 OPRL1 OPRM1 EFR3A IFNG SLC6A4 IGF1R SLC24A2 CADPS CADPS2 SLC12A7 | 3.66e-05 | 931 | 173 | 21 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CACNA2D2 ASIC2 L1CAM ANKS1B ALS2 CAV2 GRM1 EZH2 DYSF GRM5 OPRK1 OPRL1 OPRM1 EFR3A IFNG SLC6A4 IGF1R SLC24A2 CADPS CADPS2 SLC12A7 | 3.66e-05 | 931 | 173 | 21 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNA2D2 ASIC2 L1CAM ANKS1B ALS2 CAV2 GRM1 EZH2 DYSF GRM5 OPRK1 OPRL1 OPRM1 EFR3A IFNG SLC6A4 IGF1R SLC24A2 CADPS CADPS2 SLC12A7 | 4.14e-05 | 939 | 173 | 21 | GO:0099537 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | WFS1 ATP13A5 CAV2 GRM1 GRM5 SELENON ATP13A2 FZD9 SLC24A2 APLNR TRPV4 ATP13A3 | 5.32e-05 | 359 | 173 | 12 | GO:0006874 |
| GeneOntologyBiologicalProcess | UDP-N-acetylgalactosamine transmembrane transport | 6.99e-05 | 2 | 173 | 2 | GO:0015789 | |
| GeneOntologyBiologicalProcess | UDP-glucuronic acid transmembrane transport | 6.99e-05 | 2 | 173 | 2 | GO:0015787 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA2D2 ASIC2 L1CAM ANKS1B ALS2 CAV2 GRM1 EZH2 DYSF GRM5 OPRK1 OPRL1 OPRM1 EFR3A IFNG SLC6A4 IGF1R SLC24A2 CADPS CADPS2 SLC12A7 | 7.19e-05 | 976 | 173 | 21 | GO:0099536 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 8.62e-05 | 86 | 173 | 6 | GO:0007193 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 8.65e-05 | 266 | 173 | 10 | GO:0019722 | |
| GeneOntologyBiologicalProcess | chemotaxis | DPEP1 FLT1 ANXA1 L1CAM GPR183 LTB4R2 DYSF LYST SEMA4C IFNG CXCR6 TRPV4 CCR8 ACKR2 | 1.23e-04 | 517 | 173 | 14 | GO:0006935 |
| GeneOntologyBiologicalProcess | taxis | DPEP1 FLT1 ANXA1 L1CAM GPR183 LTB4R2 DYSF LYST SEMA4C IFNG CXCR6 TRPV4 CCR8 ACKR2 | 1.28e-04 | 519 | 173 | 14 | GO:0042330 |
| GeneOntologyBiologicalProcess | locomotory behavior | 1.48e-04 | 284 | 173 | 10 | GO:0007626 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic cytosolic calcium ion concentration | 1.56e-04 | 13 | 173 | 3 | GO:0099566 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC25A21 SLC35D2 ANXA1 SLC38A4 GRM1 SELENON SLCO1B1 SLC16A12 SLC35D1 SLC6A8 MPC1 SLC36A3 | 1.86e-04 | 410 | 173 | 12 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC25A21 SLC35D2 ANXA1 SLC38A4 GRM1 SELENON SLCO1B1 SLC16A12 SLC35D1 SLC6A8 MPC1 SLC36A3 | 1.94e-04 | 412 | 173 | 12 | GO:0015849 |
| GeneOntologyBiologicalProcess | polyamine transmembrane transport | 1.97e-04 | 14 | 173 | 3 | GO:1902047 | |
| GeneOntologyBiologicalProcess | negative regulation of cAMP-mediated signaling | 1.97e-04 | 14 | 173 | 3 | GO:0043951 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | SLC31A1 WFS1 TMEM199 ATP13A5 CAV2 GRM1 GRM5 SELENON ATP13A2 IFNG FZD9 SLC24A2 APLNR TRPV4 ATP13A3 | 2.05e-04 | 611 | 173 | 15 | GO:0030003 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting opioid receptor signaling pathway | 2.09e-04 | 3 | 173 | 2 | GO:0031635 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled glutamate receptor signaling pathway | 2.09e-04 | 3 | 173 | 2 | GO:0007206 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | SLC31A1 WFS1 TMEM199 ATP13A5 CAV2 GRM1 GRM5 SELENON ATP13A2 ANKH OPRK1 IFNG FZD9 IGF1R SLC24A2 APLNR TRPV4 ATP13A3 SLC12A7 NOS3 | 2.21e-04 | 981 | 173 | 20 | GO:0019725 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | FLT1 ERBB3 GPR17 L1CAM SLC44A2 GPR55 ALS2 GPR183 CAV2 GRM1 EZH2 GRM5 OPRK1 KLHL22 OPRM1 SEMA4C FZD4 IGF1R SH3GLB1 SLC20A1 LPAR6 BTK P2RY10 TRPV4 | 2.24e-04 | 1299 | 173 | 24 | GO:1902533 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | SLC31A1 WFS1 TMEM199 ATP13A5 CAV2 GRM1 GRM5 SELENON ATP13A2 IFNG FZD9 SLC24A2 APLNR TRPV4 ATP13A3 | 2.48e-04 | 622 | 173 | 15 | GO:0006873 |
| GeneOntologyBiologicalProcess | cell chemotaxis | DPEP1 FLT1 ANXA1 GPR183 DYSF LYST IFNG CXCR6 TRPV4 CCR8 ACKR2 | 2.56e-04 | 363 | 173 | 11 | GO:0060326 |
| GeneOntologyBiologicalProcess | polyamine transport | 3.62e-04 | 17 | 173 | 3 | GO:0015846 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | SLC31A1 WFS1 TMEM199 ATP13A5 CAV2 GRM1 GRM5 SELENON ATP13A2 OPRK1 IFNG FZD9 IGF1R SLC24A2 APLNR TRPV4 ATP13A3 SLC12A7 | 3.68e-04 | 866 | 173 | 18 | GO:0055082 |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA2D2 WFS1 DYSF SELENON OPRD1 OPRM1 TPCN1 SLC24A2 APLNR UBR3 TRPV4 CACNA1I NOS3 | 3.76e-04 | 509 | 173 | 13 | GO:0006816 |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 3.80e-04 | 41 | 173 | 4 | GO:0035025 | |
| GeneOntologyBiologicalProcess | lactam metabolic process | 4.15e-04 | 4 | 173 | 2 | GO:0072338 | |
| GeneOntologyBiologicalProcess | creatine transmembrane transport | 4.15e-04 | 4 | 173 | 2 | GO:0015881 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC25A21 SLC35D2 ANXA1 SLC38A4 GRM1 SELENON SLCO1B1 ANKH SLC16A12 SLC35D1 SLC6A8 MPC1 SLC36A3 | 4.20e-04 | 515 | 173 | 13 | GO:0015711 |
| GeneOntologyBiologicalProcess | estrous cycle | 5.95e-04 | 20 | 173 | 3 | GO:0044849 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 6.30e-04 | 124 | 173 | 6 | GO:0007218 | |
| GeneOntologyBiologicalProcess | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | 6.88e-04 | 5 | 173 | 2 | GO:0014834 | |
| GeneOntologyBiologicalProcess | UDP-N-acetylglucosamine transmembrane transport | 6.88e-04 | 5 | 173 | 2 | GO:1990569 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 7.40e-04 | 230 | 173 | 8 | GO:0098739 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | SLC31A1 WFS1 TMEM199 ATP13A5 CAV2 GRM1 GRM5 SELENON ATP13A2 LYST ANKH OPRK1 IFNG FZD9 IGF1R MALRD1 SLC24A2 APLNR CORIN TRPV4 ATP13A3 SLC12A7 | 7.88e-04 | 1249 | 173 | 22 | GO:0048878 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | KDELR2 IQGAP2 SLC31A1 WFS1 ANXA1 MARCHF8 TMEM199 SLC44A2 ATP13A5 CAV2 DYSF ATP13A2 OPRD1 OPRK1 TPCN1 SEMA4C FZD4 SLC6A4 MALRD1 FIG4 CADPS KDELR1 SNX27 ATP13A3 TMEM225 CADPS2 FZD2 MARCHF1 NOS3 AP3D1 | 2.92e-07 | 1307 | 172 | 30 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | KDELR2 IQGAP2 SLC31A1 WFS1 ANXA1 MARCHF8 TMEM199 SLC44A2 ATP13A5 CAV2 DYSF ATP13A2 OPRD1 OPRK1 TPCN1 SEMA4C FZD4 SLC6A4 MALRD1 FIG4 CADPS KDELR1 SNX27 ATP13A3 TMEM225 CADPS2 FZD2 MARCHF1 NOS3 AP3D1 | 3.90e-07 | 1325 | 172 | 30 | GO:0012506 |
| GeneOntologyCellularComponent | early endosome | SLC31A1 ANXA1 MARCHF8 ALS2 DYSF TPCN1 SH3GLB1 FIG4 NAE1 SNX27 ZFYVE26 ATP13A3 ACKR2 MARCHF1 AP3D1 EPHA3 | 2.45e-06 | 481 | 172 | 16 | GO:0005769 |
| GeneOntologyCellularComponent | endosome | CCZ1B FLT1 SLC31A1 ANXA1 MARCHF8 L1CAM ATP13A5 ALS2 DYSF ATP13A2 OPRM1 TPCN1 SLC6A4 SH3GLB1 CCZ1 FIG4 NAE1 SNX27 ZFYVE26 ATP13A3 ACKR2 MARCHF1 AP3D1 EPHA3 | 3.18e-05 | 1167 | 172 | 24 | GO:0005768 |
| GeneOntologyCellularComponent | synaptic membrane | ERBB3 CACNA2D2 ASIC2 ANXA1 L1CAM GRM1 GRM5 OPRD1 OPRK1 OPRL1 OPRM1 SEMA4C SLC6A4 SLC6A8 CADPS2 | 9.96e-05 | 583 | 172 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | late endosome | CCZ1B SLC31A1 MARCHF8 ATP13A5 DYSF ATP13A2 CCZ1 FIG4 ZFYVE26 ATP13A3 MARCHF1 | 1.51e-04 | 348 | 172 | 11 | GO:0005770 |
| GeneOntologyCellularComponent | early endosome membrane | 3.81e-04 | 212 | 172 | 8 | GO:0031901 | |
| GeneOntologyCellularComponent | COPI-coated vesicle membrane | 4.81e-04 | 19 | 172 | 3 | GO:0030663 | |
| GeneOntologyCellularComponent | postsynaptic membrane | ERBB3 ASIC2 GRM1 GRM5 OPRD1 OPRK1 OPRM1 SEMA4C SLC6A4 SLC6A8 CADPS2 | 5.49e-04 | 405 | 172 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 6.62e-04 | 5 | 172 | 2 | GO:0035658 | |
| GeneOntologyCellularComponent | late endosome membrane | 7.17e-04 | 179 | 172 | 7 | GO:0031902 | |
| GeneOntologyCellularComponent | sarcolemma | 1.02e-03 | 190 | 172 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | vacuolar membrane | CCZ1B MARCHF8 TMEM199 SLC44A2 ATP13A2 TPCN1 SH3GLB1 CCZ1 SLC36A3 ZFYVE26 MARCHF1 AP3D1 | 1.03e-03 | 507 | 172 | 12 | GO:0005774 |
| GeneOntologyCellularComponent | presynapse | CACNA2D2 WFS1 L1CAM ANKS1B GRM1 DYSF OPRD1 OPRK1 OPRM1 SEMA4C SLC6A4 SH3GLB1 SLC24A2 CADPS CADPS2 AP3D1 EPHA3 | 1.05e-03 | 886 | 172 | 17 | GO:0098793 |
| GeneOntologyCellularComponent | glutamatergic synapse | L1CAM ANKS1B ALS2 GRM1 GRM5 SEMA4C EFR3A FZD4 FZD9 SLC6A8 IGF1R CADPS NAE1 SNX27 CADPS2 AP3D1 | 1.20e-03 | 817 | 172 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | ERBB3 ASIC2 ANKS1B ALS2 GRM1 GRM5 OPRD1 OPRK1 OPRM1 SEMA4C SLC6A4 FZD9 SLC6A8 IGF1R SLC24A2 SNX27 CADPS2 AP3D1 | 1.87e-03 | 1018 | 172 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | presynaptic membrane | 2.14e-03 | 277 | 172 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | spine apparatus | 2.33e-03 | 9 | 172 | 2 | GO:0097444 | |
| GeneOntologyCellularComponent | COPI-coated vesicle | 2.49e-03 | 33 | 172 | 3 | GO:0030137 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DIP2B KLHL24 SLC31A1 ASIC2 WFS1 L1CAM ANKS1B ALS2 GRM1 GRM5 ATP13A2 OPRD1 OPRK1 OPRM1 FZD4 IFNG IGF1R SH3GLB1 FBXO31 EPHA3 | 2.75e-03 | 1228 | 172 | 20 | GO:0036477 |
| MousePheno | abnormal spatial learning | WFS1 L1CAM PHF8 GRM1 GRM5 ATP13A2 OPRL1 OPRM1 FZD9 SLC6A8 SLC24A2 NOS3 | 5.67e-06 | 276 | 123 | 12 | MP:0001463 |
| MousePheno | abnormal glial cell morphology | SH3TC2 ERBB3 GPR17 CACNA2D2 TMEM161B L1CAM ALS2 ATP13A2 LYST SLC6A8 FIG4 LTN1 ZFYVE26 | 1.07e-05 | 345 | 123 | 13 | MP:0003634 |
| MousePheno | hypoactivity | CACNA2D2 WFS1 L1CAM ATG2B ALS2 GRM1 SELENON ATP13A2 LYST KLHL22 OPRM1 IFNG SLC6A4 SLC6A8 PROKR2 ASB7 LTN1 CACNA1I CCR8 ATP13A3 NOS3 EPHA3 KRTCAP2 | 2.55e-05 | 1023 | 123 | 23 | MP:0031392 |
| MousePheno | decreased Purkinje cell number | 2.64e-05 | 67 | 123 | 6 | MP:0000880 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | SH3TC2 FLT1 ERBB3 SLC25A21 VGLL3 IQGAP2 CACNA2D2 WFS1 L1CAM SLC44A2 GRM1 DYSF GRM5 ATP13A2 LYST OPRD1 OPRK1 OPRL1 OPRM1 FZD4 SLC6A4 INTS10 SCN4A LTN1 TRPV4 ATP13A3 CADPS2 SLC12A7 KRTCAP2 | 2.75e-05 | 1486 | 123 | 29 | MP:0002067 |
| MousePheno | abnormal Purkinje cell number | 3.13e-05 | 69 | 123 | 6 | MP:0000878 | |
| MousePheno | abnormal skeletal muscle fiber size | 3.24e-05 | 140 | 123 | 8 | MP:0009398 | |
| MousePheno | abnormal nervous system electrophysiology | SH3TC2 CACNA2D2 ASIC2 ALS2 GRM1 GRM5 OPRM1 SLC6A4 FIG4 CACNA1I FZD2 AP3D1 | 3.28e-05 | 329 | 123 | 12 | MP:0002272 |
| MousePheno | impaired behavioral response to addictive substance | 4.48e-05 | 45 | 123 | 5 | MP:0009750 | |
| MousePheno | abnormal learning/memory/conditioning | IP6K3 WFS1 L1CAM ATG2B ADNP2 ALS2 PHF8 GRM1 GRM5 ATP13A2 OPRK1 OPRL1 OPRM1 IFNG SLC6A4 FZD9 SLC6A8 SLC24A2 ASB7 NAE1 ZFYVE26 ATP13A3 TMEM225 CADPS2 NOS3 | 6.52e-05 | 1239 | 123 | 25 | MP:0002063 |
| MousePheno | abnormal cerebellar cortex morphology | ERBB3 IP6K3 CACNA2D2 TMEM161B L1CAM ALS2 LYST SEMA4C FZD4 ZFYVE26 CADPS2 | 6.76e-05 | 300 | 123 | 11 | MP:0004097 |
| MousePheno | abnormal cognition | IP6K3 WFS1 L1CAM ATG2B ADNP2 ALS2 PHF8 GRM1 GRM5 ATP13A2 OPRK1 OPRL1 OPRM1 IFNG SLC6A4 FZD9 SLC6A8 SLC24A2 ASB7 NAE1 ZFYVE26 ATP13A3 TMEM225 CADPS2 NOS3 | 7.14e-05 | 1246 | 123 | 25 | MP:0014114 |
| MousePheno | impaired behavioral response to morphine | 7.63e-05 | 10 | 123 | 3 | MP:0009757 | |
| MousePheno | abnormal behavioral response to xenobiotic | CACNA2D2 WFS1 ANKS1B GRM5 LYST OPRD1 OPRK1 OPRL1 OPRM1 SLC6A4 FZD9 | 8.81e-05 | 309 | 123 | 11 | MP:0009745 |
| MousePheno | impaired behavioral response to xenobiotic | 8.91e-05 | 83 | 123 | 6 | MP:0009747 | |
| MousePheno | abnormal skeletal muscle fiber morphology | 1.06e-04 | 212 | 123 | 9 | MP:0003084 | |
| MousePheno | decreased locomotor activity | WFS1 L1CAM ATG2B ALS2 GRM1 SELENON ATP13A2 LYST KLHL22 OPRM1 SLC6A4 SLC6A8 PROKR2 ASB7 CACNA1I CCR8 ATP13A3 NOS3 KRTCAP2 | 1.11e-04 | 829 | 123 | 19 | MP:0001402 |
| MousePheno | abnormal chemically-elicited antinociception | 1.14e-04 | 29 | 123 | 4 | MP:0001980 | |
| MousePheno | abnormal CNS glial cell morphology | GPR17 CACNA2D2 TMEM161B ALS2 ATP13A2 LYST SLC6A8 FIG4 LTN1 ZFYVE26 | 1.43e-04 | 272 | 123 | 10 | MP:0000952 |
| MousePheno | abnormal behavioral response to morphine | 1.78e-04 | 13 | 123 | 3 | MP:0020159 | |
| MousePheno | abnormal motor learning | 1.80e-04 | 60 | 123 | 5 | MP:0002804 | |
| MousePheno | abnormal muscle regeneration | 2.45e-04 | 64 | 123 | 5 | MP:0000750 | |
| MousePheno | diluted coat color | 2.45e-04 | 64 | 123 | 5 | MP:0000371 | |
| MousePheno | abnormal behavioral response to addictive substance | 2.78e-04 | 102 | 123 | 6 | MP:0009748 | |
| MousePheno | decreased susceptibility to induced morbidity/mortality | 3.42e-04 | 106 | 123 | 6 | MP:0009764 | |
| MousePheno | abnormal fear/anxiety-related behavior | WDR64 ASIC2 WFS1 L1CAM ATG2B ALS2 PHF8 OPRD1 IFNG SLC6A4 LPAR6 LTN1 CCR8 ATP13A3 TMEM225 CADPS2 NOS3 EPHA3 KRTCAP2 | 4.13e-04 | 919 | 123 | 19 | MP:0002065 |
| MousePheno | abnormal Purkinje cell morphology | 4.40e-04 | 204 | 123 | 8 | MP:0000877 | |
| MousePheno | abnormal serotonin level | 4.53e-04 | 73 | 123 | 5 | MP:0005322 | |
| MousePheno | decreased neuron number | ERBB3 CACNA2D2 SLC44A2 ALS2 LYST CDC14A FZD4 OR8A1 IGF1R CADPS2 SLC12A7 | 4.80e-04 | 376 | 123 | 11 | MP:0008948 |
| MousePheno | abnormal cerebellar layer morphology | 5.24e-04 | 263 | 123 | 9 | MP:0009956 | |
| MousePheno | abnormal ventral spinal root morphology | 5.81e-04 | 19 | 123 | 3 | MP:0003993 | |
| MousePheno | decreased chemically-elicited antinociception | 5.81e-04 | 19 | 123 | 3 | MP:0001982 | |
| Domain | 7tm_1 | OR5M10 GPR17 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 TAAR2 GPR55 OR2J3 OR2J2 GPR183 LTB4R2 OR1J4 OR1L3 OR6P1 OR1L1 OPRD1 OPRK1 OPRL1 OPRM1 OR10G6 OR1L8 OR8A1 PROKR2 OR10G2 CXCR6 LPAR6 APLNR OR1L6 OR1G1 P2RY10 CCR8 ACKR2 OR1L4 | 7.40e-17 | 677 | 173 | 35 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5M10 GPR17 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 TAAR2 GPR55 OR2J3 OR2J2 GPR183 LTB4R2 OR1J4 OR1L3 OR6P1 OR1L1 OPRD1 OPRK1 OPRL1 OPRM1 OR10G6 OR1L8 OR8A1 PROKR2 OR10G2 CXCR6 LPAR6 APLNR OR1L6 OR1G1 P2RY10 CCR8 ACKR2 OR1L4 | 1.06e-16 | 685 | 173 | 35 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5M10 GPR17 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 TAAR2 GPR55 OR2J3 OR2J2 GPR183 LTB4R2 OR1J4 OR1L3 OR6P1 OR1L1 OPRD1 OPRK1 OPRL1 OPRM1 OR10G6 OR1L8 OR8A1 PROKR2 OR10G2 CXCR6 LPAR6 APLNR OR1L6 OR1G1 P2RY10 CCR8 ACKR2 OR1L4 | 1.39e-16 | 691 | 173 | 35 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5M10 GPR17 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 TAAR2 GPR55 OR2J3 OR2J2 GPR183 LTB4R2 OR1J4 OR1L3 OR6P1 OR1L1 OPRD1 OPRK1 OPRL1 OPRM1 OR10G6 OR1L8 OR8A1 PROKR2 OR10G2 CXCR6 LPAR6 APLNR OR1L6 OR1G1 P2RY10 CCR8 ACKR2 OR1L4 | 1.45e-16 | 692 | 173 | 35 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR5M10 GPR17 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 TAAR2 GPR55 OR2J3 OR2J2 GPR183 LTB4R2 OR1J4 OR1L3 OR6P1 OR1L1 OPRD1 OPRK1 OPRL1 OPRM1 OR1L8 OR8A1 PROKR2 OR10G2 CXCR6 LPAR6 APLNR OR1L6 OR1G1 P2RY10 CCR8 ACKR2 OR1L4 | 3.82e-16 | 670 | 173 | 34 | IPR017452 |
| Domain | Olfact_rcpt | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 OR10G2 OR1L6 OR1G1 OR1L4 | 4.54e-09 | 393 | 173 | 19 | IPR000725 |
| Domain | Opioid_rcpt | 7.11e-09 | 4 | 173 | 4 | IPR001418 | |
| Domain | P5-ATPase | 3.10e-06 | 4 | 173 | 3 | PF12409 | |
| Domain | P-type_TPase_V | 7.70e-06 | 5 | 173 | 3 | IPR006544 | |
| Domain | FRI | 3.07e-05 | 20 | 173 | 4 | SM00063 | |
| Domain | - | 3.76e-05 | 21 | 173 | 4 | 1.10.2000.10 | |
| Domain | Frizzled_dom | 6.54e-05 | 24 | 173 | 4 | IPR020067 | |
| Domain | FZ | 6.54e-05 | 24 | 173 | 4 | PS50038 | |
| Domain | Fz | 6.54e-05 | 24 | 173 | 4 | PF01392 | |
| Domain | GluR_Homer-bdg | 8.53e-05 | 2 | 173 | 2 | PF10606 | |
| Domain | CAPS | 8.53e-05 | 2 | 173 | 2 | IPR033227 | |
| Domain | Metabotropic_Glu_rcpt_Homer-bd | 8.53e-05 | 2 | 173 | 2 | IPR019588 | |
| Domain | GPCR_3_mtglu_rcpt_1 | 8.53e-05 | 2 | 173 | 2 | IPR001256 | |
| Domain | GluR_Homer-bdg | 8.53e-05 | 2 | 173 | 2 | SM01229 | |
| Domain | DUF1712 | 8.53e-05 | 2 | 173 | 2 | PF08217 | |
| Domain | GPCR_3_mtglu_rcpt_5 | 8.53e-05 | 2 | 173 | 2 | IPR000202 | |
| Domain | DUF1712_fun | 8.53e-05 | 2 | 173 | 2 | IPR013176 | |
| Domain | Frizzled | 1.22e-04 | 11 | 173 | 3 | IPR000539 | |
| Domain | Frizzled | 1.22e-04 | 11 | 173 | 3 | PF01534 | |
| Domain | Frizzled | 1.22e-04 | 11 | 173 | 3 | SM01330 | |
| Domain | ER_ret_rcpt | 2.54e-04 | 3 | 173 | 2 | IPR000133 | |
| Domain | ER_lumen_recept | 2.54e-04 | 3 | 173 | 2 | PF00810 | |
| Domain | ER_LUMEN_RECEPTOR_1 | 2.54e-04 | 3 | 173 | 2 | PS00951 | |
| Domain | ER_LUMEN_RECEPTOR_2 | 2.54e-04 | 3 | 173 | 2 | PS00952 | |
| Domain | Chemokine_rcpt | 4.00e-04 | 16 | 173 | 3 | IPR000355 | |
| Domain | Frizzled/SFRP | 4.00e-04 | 16 | 173 | 3 | IPR015526 | |
| Domain | Znf_RING-CH | 4.83e-04 | 17 | 173 | 3 | IPR011016 | |
| Domain | RINGv | 4.83e-04 | 17 | 173 | 3 | SM00744 | |
| Domain | FN3 | 5.45e-04 | 199 | 173 | 8 | PS50853 | |
| Domain | 7TM_GPCR_Srsx | 6.16e-04 | 112 | 173 | 6 | SM01381 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.79e-04 | 19 | 173 | 3 | IPR004014 | |
| Domain | FN3_dom | 7.51e-04 | 209 | 173 | 8 | IPR003961 | |
| Domain | DUF1041 | 8.38e-04 | 5 | 173 | 2 | SM01145 | |
| Domain | Tyr_kinase_cat_dom | 1.36e-03 | 88 | 173 | 5 | IPR020635 | |
| Domain | TyrKc | 1.36e-03 | 88 | 173 | 5 | SM00219 | |
| Domain | Munc13_1 | 1.74e-03 | 7 | 173 | 2 | IPR014770 | |
| Domain | MHD1 | 1.74e-03 | 7 | 173 | 2 | PS51258 | |
| Domain | Recep_L_domain | 1.74e-03 | 7 | 173 | 2 | PF01030 | |
| Domain | DUF1041 | 1.74e-03 | 7 | 173 | 2 | PF06292 | |
| Domain | Furin-like | 1.74e-03 | 7 | 173 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 1.74e-03 | 7 | 173 | 2 | IPR000494 | |
| Domain | CAPS_dom | 1.74e-03 | 7 | 173 | 2 | IPR010439 | |
| Domain | Furin-like_Cys-rich_dom | 1.74e-03 | 7 | 173 | 2 | IPR006211 | |
| Domain | - | 1.74e-03 | 7 | 173 | 2 | 3.80.20.20 | |
| Domain | PROTEIN_KINASE_TYR | 2.09e-03 | 97 | 173 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.09e-03 | 97 | 173 | 5 | IPR008266 | |
| Domain | Gal_Oxase/kelch_b-propeller | 2.18e-03 | 59 | 173 | 4 | IPR011043 | |
| Domain | MARCH-like | 2.30e-03 | 8 | 173 | 2 | IPR033275 | |
| Domain | GPCR_3_mtglu_rcpt | 2.30e-03 | 8 | 173 | 2 | IPR000162 | |
| Domain | GPCR_2_secretin-like | 2.32e-03 | 60 | 173 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 2.32e-03 | 60 | 173 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.46e-03 | 61 | 173 | 4 | PS50261 | |
| Domain | - | 3.18e-03 | 32 | 173 | 3 | 3.40.1110.10 | |
| Domain | - | 3.18e-03 | 32 | 173 | 3 | 2.70.150.10 | |
| Domain | Interfer-bind | 3.66e-03 | 10 | 173 | 2 | PF09294 | |
| Domain | Sugar_P_trans_dom | 3.66e-03 | 10 | 173 | 2 | IPR004853 | |
| Domain | Interferon/interleukin_rcp_dom | 3.66e-03 | 10 | 173 | 2 | IPR015373 | |
| Domain | TPT | 3.66e-03 | 10 | 173 | 2 | PF03151 | |
| Domain | ATPase_P-typ_cyto_domN | 4.11e-03 | 35 | 173 | 3 | IPR023299 | |
| Domain | ZF_RING_CH | 4.44e-03 | 11 | 173 | 2 | PS51292 | |
| Domain | RINGv | 4.44e-03 | 11 | 173 | 2 | PF12906 | |
| Domain | ATPase_P-typ_P_site | 4.46e-03 | 36 | 173 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 4.46e-03 | 36 | 173 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 4.46e-03 | 36 | 173 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.82e-03 | 37 | 173 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.82e-03 | 37 | 173 | 3 | PF00122 | |
| Domain | Tissue_fac | 5.30e-03 | 12 | 173 | 2 | PF01108 | |
| Domain | Tissue_factor | 5.30e-03 | 12 | 173 | 2 | IPR001187 | |
| Domain | NCD3G | 6.22e-03 | 13 | 173 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 6.22e-03 | 13 | 173 | 2 | IPR011500 | |
| Domain | Pkinase_Tyr | 7.04e-03 | 129 | 173 | 5 | PF07714 | |
| Domain | GPCR_3_CS | 7.22e-03 | 14 | 173 | 2 | IPR017979 | |
| Domain | BTB-kelch_protein | 7.35e-03 | 43 | 173 | 3 | IPR017096 | |
| Domain | FN3 | 7.61e-03 | 185 | 173 | 6 | SM00060 | |
| Pathway | WP_GPCRS_NONODORANT | GPR17 LTB4R2 GRM1 GRM5 PTH2R OPRD1 OPRK1 OPRM1 FZD4 FZD9 TAS2R1 PROKR2 CXCR6 LPAR6 APLNR P2RY10 CCR8 ACKR2 FZD2 | 8.41e-12 | 266 | 135 | 19 | MM15843 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GPR17 ANXA1 TAAR2 GPR55 GPR183 LTB4R2 GRM1 GRM5 PTH2R OPRD1 OPRK1 OPRL1 OPRM1 FZD4 FZD9 TAS2R1 PROKR2 CXCR6 LPAR6 APLNR P2RY10 CCR8 ACKR2 FZD2 | 1.16e-11 | 463 | 135 | 24 | M507 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GPR17 ANXA1 TAAR2 GPR55 GPR183 LTB4R2 GRM1 GRM5 PTH2R OPRD1 OPRK1 OPRL1 OPRM1 TAS2R1 PROKR2 CXCR6 LPAR6 APLNR P2RY10 CCR8 ACKR2 | 7.68e-10 | 430 | 135 | 21 | MM15160 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | GPR17 ANXA1 TAAR2 GPR55 GPR183 LTB4R2 GRM1 GRM5 PTH2R OPRD1 OPRK1 OPRL1 OPRM1 FZD4 FZD9 TAS2R1 PROKR2 CXCR6 LPAR6 BTK APLNR P2RY10 CCR8 ACKR2 FZD2 | 1.07e-08 | 702 | 135 | 25 | M746 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 OR10G2 OR1L6 OR1G1 OR1L4 | 1.65e-08 | 417 | 135 | 19 | M4072 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | GPR17 ANXA1 TAAR2 GPR55 GPR183 LTB4R2 OPRD1 OPRK1 OPRL1 OPRM1 PROKR2 CXCR6 LPAR6 APLNR P2RY10 CCR8 ACKR2 | 1.67e-08 | 330 | 135 | 17 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | GPR17 ANXA1 TAAR2 GPR55 GPR183 LTB4R2 OPRD1 OPRK1 OPRL1 OPRM1 PROKR2 CXCR6 LPAR6 APLNR P2RY10 CCR8 ACKR2 | 1.91e-08 | 333 | 135 | 17 | MM14963 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR5M10 OR9A4 OR5M1 CACNA2D2 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 GRM1 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 TAS2R1 OR10G2 OR1L6 OR1G1 GPC5 OR1L4 | 3.41e-08 | 636 | 135 | 23 | M41834 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR1L1 OR1L8 OR8A1 OR10G2 OR1L6 OR1G1 OR1L4 | 1.82e-07 | 389 | 135 | 17 | M14091 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | GPR17 ANXA1 TAAR2 GPR55 GPR183 LTB4R2 GRM1 GRM5 PTH2R OPRD1 OPRK1 OPRL1 OPRM1 TAS2R1 PROKR2 CXCR6 LPAR6 BTK APLNR P2RY10 CCR8 ACKR2 | 2.00e-07 | 646 | 135 | 22 | MM14962 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GPR17 OR2J3 OR2J2 OPRD1 OPRK1 OPRL1 OPRM1 LPAR6 APLNR OR1G1 P2RY10 CCR8 ACKR2 | 1.25e-06 | 260 | 135 | 13 | M39397 |
| Pathway | WP_GPCRS_OTHER | 2.95e-06 | 93 | 135 | 8 | M39629 | |
| Pathway | WP_GPCRS_OTHER | 3.75e-06 | 96 | 135 | 8 | MM15939 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | TAAR2 LTB4R2 GRM1 GRM5 PTH2R OPRD1 OPRK1 OPRL1 OPRM1 LPAR6 APLNR P2RY10 | 1.18e-05 | 272 | 135 | 12 | M13380 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.96e-05 | 197 | 135 | 10 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.96e-05 | 197 | 135 | 10 | MM14970 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | GPR17 ANXA1 GPR55 GPR183 OPRD1 OPRK1 OPRL1 OPRM1 TAS2R1 CXCR6 APLNR CCR8 | 2.15e-05 | 289 | 135 | 12 | MM15057 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | GPR17 ANXA1 GPR55 GPR183 OPRD1 OPRK1 OPRL1 OPRM1 TAS2R1 CXCR6 APLNR CCR8 | 4.84e-05 | 314 | 135 | 12 | M600 |
| Pathway | WP_GPCRS_PEPTIDE | 5.47e-05 | 70 | 135 | 6 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 8.08e-05 | 75 | 135 | 6 | M39696 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 1.34e-04 | 11 | 135 | 3 | MM15049 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 1.77e-04 | 12 | 135 | 3 | M10960 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.88e-04 | 210 | 135 | 9 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 2.40e-04 | 217 | 135 | 9 | M18437 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 2.89e-04 | 14 | 135 | 3 | M47834 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 4.20e-04 | 186 | 135 | 8 | MM15994 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 4.39e-04 | 16 | 135 | 3 | MM15050 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 4.39e-04 | 16 | 135 | 3 | M47823 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 4.39e-04 | 16 | 135 | 3 | M6786 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC31A1 SLC35D2 SLC38A4 SLC44A2 SLCO1B1 SLC35D1 SLC24A2 SLC20A1 SLC12A7 | 4.74e-04 | 238 | 135 | 9 | MM15076 |
| Pathway | BIOCARTA_GCR_PATHWAY | 5.29e-04 | 17 | 135 | 3 | M10066 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 5.29e-04 | 17 | 135 | 3 | MM1372 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC31A1 SLC35D2 SLC38A4 SLC44A2 SLCO1B1 SLC35D1 SLC24A2 SLC20A1 SLC12A7 | 6.56e-04 | 249 | 135 | 9 | M5988 |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO | 7.44e-04 | 19 | 135 | 3 | M47833 | |
| Pathway | REACTOME_LEUKOTRIENE_RECEPTORS | 8.93e-04 | 5 | 135 | 2 | M27305 | |
| Pathway | REACTOME_LEUKOTRIENE_RECEPTORS | 8.93e-04 | 5 | 135 | 2 | MM15013 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 1.33e-03 | 85 | 135 | 5 | M48315 | |
| Pubmed | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2G3 OR2J3 OR2J2 OR1J4 OR1L3 OR6P1 OR1L1 OR10G6 OR1L8 OR8A1 OR10G2 OR1L6 OR1G1 OR1L4 | 4.25e-11 | 541 | 175 | 19 | 14983052 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2J3 OR2J2 OR1J4 OR6P1 OR10G6 OR1L8 OR8A1 OR10G2 OR1L6 OR1L4 | 2.33e-10 | 340 | 175 | 15 | 11875048 |
| Pubmed | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2J3 OR2J2 OR1J4 OR6P1 OR10G6 OR1L8 OR8A1 OR10G2 OR1L6 OR1L4 | 2.33e-10 | 340 | 175 | 15 | 11802173 | |
| Pubmed | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2J3 OR2J2 OR1J4 OR6P1 OR10G6 OR1L8 OR8A1 OR10G2 OR1L6 OR1L4 | 2.63e-10 | 343 | 175 | 15 | 32295537 | |
| Pubmed | OR5M10 OR9A4 OR5M1 OR1S1 OR1S2 OR2J3 OR2J2 OR1J4 OR6P1 OR10G6 OR1L8 OR8A1 OR10G2 OR1L6 OR1L4 | 2.97e-10 | 346 | 175 | 15 | 14611657 | |
| Pubmed | TAAR2 GPR55 PTH2R OPRD1 OPRK1 OPRL1 OPRM1 CXCR6 LPAR6 APLNR P2RY10 CCR8 | 4.85e-10 | 200 | 175 | 12 | 18240029 | |
| Pubmed | 6.19e-10 | 4 | 175 | 4 | 11430857 | ||
| Pubmed | Multiple opioid receptor-like genes are identified in diverse vertebrate phyla. | 6.19e-10 | 4 | 175 | 4 | 8941707 | |
| Pubmed | 9.22e-09 | 6 | 175 | 4 | 12044478 | ||
| Pubmed | 2.78e-08 | 179 | 175 | 10 | 18577758 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 10082819 | ||
| Pubmed | Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. | 1.25e-07 | 3 | 175 | 3 | 18537939 | |
| Pubmed | Opioid receptors: from binding sites to visible molecules in vivo. | 1.25e-07 | 3 | 175 | 3 | 18718480 | |
| Pubmed | Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. | 1.25e-07 | 3 | 175 | 3 | 11069979 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 19032295 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 15090050 | ||
| Pubmed | Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. | 1.25e-07 | 3 | 175 | 3 | 18338799 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 26692286 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 17374034 | ||
| Pubmed | Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice. | 1.25e-07 | 3 | 175 | 3 | 12431223 | |
| Pubmed | Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphisms. | 1.25e-07 | 3 | 175 | 3 | 26946441 | |
| Pubmed | Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. | 1.25e-07 | 3 | 175 | 3 | 11826143 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 12603260 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 15178356 | ||
| Pubmed | Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. | 1.25e-07 | 3 | 175 | 3 | 8114680 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 11032994 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 25855262 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 18213616 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 17676326 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 11504820 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 28049031 | ||
| Pubmed | Nociception increases during opioid infusion in opioid receptor triple knock-out mice. | 1.25e-07 | 3 | 175 | 3 | 17544222 | |
| Pubmed | Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. | 1.25e-07 | 3 | 175 | 3 | 14745298 | |
| Pubmed | Opioid receptor characterisation of neuronally stimulated isolated human vas deferens. | 1.25e-07 | 3 | 175 | 3 | 22752269 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 24874714 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 33555255 | ||
| Pubmed | Enhanced humoral response in kappa-opioid receptor knockout mice. | 1.25e-07 | 3 | 175 | 3 | 12507774 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 14975676 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 12413885 | ||
| Pubmed | Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. | 4.99e-07 | 4 | 175 | 3 | 9502813 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 30249798 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 16053916 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | TMEM144 GPR17 WFS1 TMEM199 SLC44A2 LTB4R2 GRM1 OPRL1 KLHL22 OPRM1 SLC6A8 P4HTM HS6ST1 APLNR KDELR1 CCR8 | 5.46e-07 | 697 | 175 | 16 | 28298427 |
| Pubmed | Identification of a novel family of G protein-coupled receptor associated sorting proteins. | 5.96e-07 | 14 | 175 | 4 | 15086532 | |
| Pubmed | Characterization of the P5 subfamily of P-type transport ATPases in mice. | 1.24e-06 | 5 | 175 | 3 | 15381061 | |
| Pubmed | Parkinson disease related ATP13A2 evolved early in animal evolution. | 1.24e-06 | 5 | 175 | 3 | 29505581 | |
| Pubmed | 1.24e-06 | 5 | 175 | 3 | 33782947 | ||
| Pubmed | Variations in opioid receptor genes in neonatal abstinence syndrome. | 1.24e-06 | 5 | 175 | 3 | 26233486 | |
| Pubmed | Genetic susceptibility to heroin addiction: a candidate gene association study. | 2.48e-06 | 6 | 175 | 3 | 18518925 | |
| Pubmed | Expression of opioid receptors and ligands in pregnant mouse uterus and placenta. | 2.48e-06 | 6 | 175 | 3 | 9746745 | |
| Pubmed | 3.54e-06 | 81 | 175 | 6 | 22723691 | ||
| Pubmed | 3.76e-06 | 179 | 175 | 8 | 19074885 | ||
| Pubmed | Preimplantation mouse embryo is a target for opioid ligand-receptor signaling. | 6.88e-06 | 8 | 175 | 3 | 24855103 | |
| Pubmed | A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. | 1.03e-05 | 9 | 175 | 3 | 9707618 | |
| Pubmed | A large-scale candidate gene association study of age at menarche and age at natural menopause. | 1.16e-05 | 275 | 175 | 9 | 20734064 | |
| Pubmed | Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. | 1.46e-05 | 10 | 175 | 3 | 17982459 | |
| Pubmed | Expression of Frizzled genes in developing and postnatal hair follicles. | 1.46e-05 | 10 | 175 | 3 | 15245425 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 1.64e-05 | 219 | 175 | 8 | 12213199 | |
| Pubmed | CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. | 1.99e-05 | 163 | 175 | 7 | 23333304 | |
| Pubmed | 2.01e-05 | 11 | 175 | 3 | 19084435 | ||
| Pubmed | 2.01e-05 | 11 | 175 | 3 | 17576136 | ||
| Pubmed | 2.01e-05 | 11 | 175 | 3 | 17582687 | ||
| Pubmed | Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells. | 2.01e-05 | 11 | 175 | 3 | 24860427 | |
| Pubmed | Role of inflammation gene polymorphisms on pain severity in lung cancer patients. | 2.26e-05 | 33 | 175 | 4 | 19773451 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 18177725 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 22028929 | ||
| Pubmed | Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents. | 2.52e-05 | 2 | 175 | 2 | 31815916 | |
| Pubmed | Association Between Genetic Polymorphisms and Pain Sensitivity in Patients with Hip Osteoarthritis. | 2.52e-05 | 2 | 175 | 2 | 29055075 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 23836900 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 24278116 | ||
| Pubmed | The role of EZH2 and DNA methylation in hMLH1 silencing in epithelial ovarian cancer. | 2.52e-05 | 2 | 175 | 2 | 23523787 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 21262959 | ||
| Pubmed | Lymphoblastic lymphoma in a colony of N:NIH(S)-bg-nu-xid mice. | 2.52e-05 | 2 | 175 | 2 | 1434498 | |
| Pubmed | Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors. | 2.52e-05 | 2 | 175 | 2 | 24651466 | |
| Pubmed | Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease. | 2.52e-05 | 2 | 175 | 2 | 30152845 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 23073238 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 28883501 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 24628914 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 17373650 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 32215825 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 23158928 | ||
| Pubmed | Mu and delta opioid receptor knockout mice show increased colonic sensitivity. | 2.52e-05 | 2 | 175 | 2 | 27748566 | |
| Pubmed | Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. | 2.52e-05 | 2 | 175 | 2 | 12559117 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 15657030 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 18554818 | ||
| Pubmed | Distribution of delta and mu opioid receptor mRNA in rodent dorsal root ganglia neurons. | 2.52e-05 | 2 | 175 | 2 | 35674691 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16331961 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 15748148 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 27392515 | ||
| Pubmed | CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles. | 2.52e-05 | 2 | 175 | 2 | 18495893 | |
| Pubmed | A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. | 2.52e-05 | 2 | 175 | 2 | 24623156 | |
| Pubmed | Identification of kappa- and delta-opioid receptor transcripts in immune cells. | 2.52e-05 | 2 | 175 | 2 | 7649271 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 27270750 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 9194936 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 22106286 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 17185983 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 18035501 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 30738575 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 11591458 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 9155012 | ||
| Interaction | MZT2B interactions | 8.61e-08 | 74 | 152 | 8 | int:MZT2B | |
| Interaction | BRAT1 interactions | 5.60e-07 | 94 | 152 | 8 | int:BRAT1 | |
| Interaction | LMBRD2 interactions | 5.83e-07 | 65 | 152 | 7 | int:LMBRD2 | |
| Interaction | GPRASP1 interactions | 7.20e-07 | 67 | 152 | 7 | int:GPRASP1 | |
| Interaction | INTS1 interactions | 7.40e-06 | 175 | 152 | 9 | int:INTS1 | |
| Interaction | FASTKD1 interactions | 7.67e-06 | 95 | 152 | 7 | int:FASTKD1 | |
| Interaction | DEGS1 interactions | 1.14e-05 | 67 | 152 | 6 | int:DEGS1 | |
| Interaction | YIPF3 interactions | 1.21e-05 | 186 | 152 | 9 | int:YIPF3 | |
| Interaction | INTS2 interactions | 1.23e-05 | 102 | 152 | 7 | int:INTS2 | |
| Interaction | ATL2 interactions | 1.39e-05 | 104 | 152 | 7 | int:ATL2 | |
| Interaction | DNAAF5 interactions | 2.58e-05 | 157 | 152 | 8 | int:DNAAF5 | |
| Interaction | ADCK1 interactions | 2.94e-05 | 79 | 152 | 6 | int:ADCK1 | |
| Interaction | HACD2 interactions | 3.64e-05 | 82 | 152 | 6 | int:HACD2 | |
| Interaction | EXOC6 interactions | 3.90e-05 | 83 | 152 | 6 | int:EXOC6 | |
| Interaction | TSPAN15 interactions | GPR17 WFS1 ATP13A2 TPCN1 FZD4 SLC20A1 LPAR6 SCN4A ATP13A3 FZD2 | 4.80e-05 | 276 | 152 | 10 | int:TSPAN15 |
| Interaction | GJA4 interactions | 4.86e-05 | 10 | 152 | 3 | int:GJA4 | |
| Interaction | TMEM161B interactions | 5.53e-05 | 28 | 152 | 4 | int:TMEM161B | |
| Interaction | AUP1 interactions | 7.32e-05 | 234 | 152 | 9 | int:AUP1 | |
| Interaction | ABHD17B interactions | 8.24e-05 | 59 | 152 | 5 | int:ABHD17B | |
| Interaction | GRM1 interactions | 1.05e-04 | 62 | 152 | 5 | int:GRM1 | |
| Interaction | JAK1 interactions | 1.14e-04 | 248 | 152 | 9 | int:JAK1 | |
| Interaction | ACAD10 interactions | 1.24e-04 | 102 | 152 | 6 | int:ACAD10 | |
| Interaction | C11orf52 interactions | DIP2B IQGAP2 FAM83B SEMA4C EFR3A SLC6A8 IGF1R ATP13A3 SLC12A7 EPHA3 | 1.29e-04 | 311 | 152 | 10 | int:C11orf52 |
| Interaction | CHPT1 interactions | 1.31e-04 | 65 | 152 | 5 | int:CHPT1 | |
| Interaction | CERS6 interactions | 1.38e-04 | 104 | 152 | 6 | int:CERS6 | |
| Interaction | NDUFB3 interactions | 1.78e-04 | 109 | 152 | 6 | int:NDUFB3 | |
| Cytoband | 9q33.2 | 3.94e-07 | 39 | 175 | 5 | 9q33.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 1.60e-05 | 138 | 175 | 6 | chr9q33 | |
| Cytoband | 7p22.1 | 3.20e-05 | 47 | 175 | 4 | 7p22.1 | |
| Cytoband | 3p21.3 | 7.88e-05 | 59 | 175 | 4 | 3p21.3 | |
| Cytoband | 5p15 | 3.00e-04 | 7 | 175 | 2 | 5p15 | |
| Cytoband | 11q12.1 | 3.98e-04 | 161 | 175 | 5 | 11q12.1 | |
| Cytoband | 6q24 | 3.98e-04 | 8 | 175 | 2 | 6q24 | |
| Cytoband | 2q21 | 1.28e-03 | 14 | 175 | 2 | 2q21 | |
| GeneFamily | Olfactory receptors, family 1 | 1.01e-11 | 40 | 132 | 9 | 147 | |
| GeneFamily | Opioid receptors | 2.71e-09 | 4 | 132 | 4 | 245 | |
| GeneFamily | Solute carriers | SLC25A21 SLC31A1 SLC35D2 SLC38A4 SLC44A2 SLCO1B1 SLC16A12 SLC35D1 SLC6A4 SLC6A8 SLC24A2 SLC20A1 SLC36A3 SLC12A7 | 1.19e-06 | 395 | 132 | 14 | 752 |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 3.76e-06 | 5 | 132 | 3 | 1213 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 6.01e-05 | 11 | 132 | 3 | 286 | |
| GeneFamily | Fibronectin type III domain containing | 1.14e-03 | 160 | 132 | 6 | 555 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.44e-03 | 8 | 132 | 2 | 281 | |
| GeneFamily | Ring finger proteins|Membrane associated ring-CH-type fingers | 2.79e-03 | 11 | 132 | 2 | 60 | |
| GeneFamily | Kelch like|BTB domain containing | 3.55e-03 | 42 | 132 | 3 | 617 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 3.55e-03 | 42 | 132 | 3 | 602 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.61e-07 | 64 | 157 | 7 | gudmap_kidney_e15.5_Podocyte_MafB_k1_1000 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-08 | 179 | 175 | 9 | d56fa2a0b119d51a8d41b00fbbd7dfddefeb279c | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-08 | 179 | 175 | 9 | e0542694fa79d67f67be6f85b4fa6d18f7523253 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-08 | 179 | 175 | 9 | 83343b68977969c7978acd930a66fc7c44df6a15 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-08 | 181 | 175 | 9 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-08 | 190 | 175 | 9 | da2fcd4a2cc6e45c8174109d892f1424e39919a1 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-08 | 190 | 175 | 9 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-08 | 190 | 175 | 9 | 3395b2ff6ffadf84cdb1b5a37a5b6be05b56c30f | |
| ToppCell | facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-08 | 190 | 175 | 9 | 65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.65e-08 | 190 | 175 | 9 | 2655df8c0883dd811fa7617301f9c4b0a4dd55ec | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-08 | 190 | 175 | 9 | e584eaccbc22aa7f7a4340ed8a2a8b45ddca93f4 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-08 | 191 | 175 | 9 | a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-08 | 191 | 175 | 9 | 827be47d3574c6c5b021c6f1c1670834344f10cb | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-08 | 195 | 175 | 9 | 8493f2f60fc356af28b9c0e287d4cd8c8899c081 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-08 | 195 | 175 | 9 | 5e5ca7bd94c9e924ed76f7ccac199be745d4c4eb | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-07 | 200 | 175 | 9 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.90e-07 | 180 | 175 | 8 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-07 | 181 | 175 | 8 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-07 | 182 | 175 | 8 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-07 | 183 | 175 | 8 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-07 | 186 | 175 | 8 | 41f1674afc17661eccaa779cdeb663db5e45685d | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-07 | 186 | 175 | 8 | d72cdbb6d79ab33a5823c42e93c2ba566244f64c | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-07 | 186 | 175 | 8 | aa006650cf21a2c51dfe1091681f67fdad939107 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-07 | 187 | 175 | 8 | d72012e94857606f39975cf672f6b8c2e0fe093e | |
| ToppCell | facs-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.19e-07 | 188 | 175 | 8 | dd817059e1b4225e84733559f7839cc973b7dfd6 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.19e-07 | 188 | 175 | 8 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.19e-07 | 188 | 175 | 8 | 6ab5ce8569f896a0fe7a76b8b4a83661e5499b8c | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.19e-07 | 188 | 175 | 8 | 20072a2a3f9ecbe727c850629f19420cf60e4bc5 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-07 | 189 | 175 | 8 | f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-07 | 189 | 175 | 8 | e3d65417997bdd3f9c312c0977dceb6eca061029 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-07 | 189 | 175 | 8 | 5559af03d9d612bb8dcf825e45744a9f8332bac8 | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-07 | 190 | 175 | 8 | ee63dc04e91ad49aa7820c98e97261176ecebaa6 | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-07 | 190 | 175 | 8 | b0c9dae8189d407c94964c6bfe3ef92035245357 | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-07 | 190 | 175 | 8 | 0e50808bfc3d0820524c8470ae3e8250819d65b2 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-07 | 191 | 175 | 8 | 6b9bbf4a63d4e9a8075bb06c2aa644fcf4ee88b8 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.23e-07 | 191 | 175 | 8 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.23e-07 | 191 | 175 | 8 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | facs-Heart-RV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-07 | 191 | 175 | 8 | 84ebb9f8e975acc88aa600c08a8aa791256948a6 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-07 | 191 | 175 | 8 | a0018f88f7132477cc467ee15db029a585290595 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-07 | 191 | 175 | 8 | 90f0c193dce267a4f1a9b2501f636dafd0a34cf7 | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-07 | 193 | 175 | 8 | e164f6403a8b541ced08a6feec915d2e855036ea | |
| ToppCell | facs-MAT-Fat-3m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-07 | 193 | 175 | 8 | b32533afeff1905e188becaa09079e9699722e4b | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-07 | 193 | 175 | 8 | 2ff573ba2c74583ed1cb071a3bbc01bb71117e5f | |
| ToppCell | facs-Kidney-nan-3m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 194 | 175 | 8 | 5fa2dfca32cca4abfda0af90b83f2b2a826f9b6e | |
| ToppCell | facs-Kidney-nan-3m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 194 | 175 | 8 | 04df35246287815bdd28adaf885bdb98cf49524e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 194 | 175 | 8 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | facs-Kidney-nan-3m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 194 | 175 | 8 | 90928d6c96c6304ae35dcc0275f7889de93da100 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 195 | 175 | 8 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 196 | 175 | 8 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 196 | 175 | 8 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 196 | 175 | 8 | 039044ab28c53391c34d8226fb8cf78549e63ef4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-06 | 197 | 175 | 8 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-06 | 199 | 175 | 8 | ef7f7f7c861827574b120f48cf4052c563929081 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-06 | 199 | 175 | 8 | 41f046646fff65b7e51b63d3204f76ef32054781 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.30e-06 | 200 | 175 | 8 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.30e-06 | 200 | 175 | 8 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.30e-06 | 200 | 175 | 8 | e786544cf6f891550c4be55ebb4928c92297b504 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.30e-06 | 200 | 175 | 8 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.30e-06 | 200 | 175 | 8 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.30e-06 | 200 | 175 | 8 | 2488aa12970a43a5af352e2c36c73884d73a1cc5 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.30e-06 | 200 | 175 | 8 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.30e-06 | 200 | 175 | 8 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.11e-06 | 158 | 175 | 7 | 78b48b110b777bcc4c07cd23388bee911c0231d6 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 162 | 175 | 7 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 162 | 175 | 7 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 162 | 175 | 7 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 170 | 175 | 7 | aff226a84e397ab58204325aa9d8b396a881986e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 170 | 175 | 7 | 6af16e6f276aec6389ece99505ba13c7edc4c4fa | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-06 | 171 | 175 | 7 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 171 | 175 | 7 | 246fc7edcefc47437d1df6029f295aca3b34b2b2 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 171 | 175 | 7 | 1fb4e11f92b48dc2d6e553c22e2571bbd8c223c6 | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 5.44e-06 | 172 | 175 | 7 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.65e-06 | 173 | 175 | 7 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.65e-06 | 173 | 175 | 7 | ad9777e4ae70b11676ec735eb6db91776ca0cb19 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-06 | 173 | 175 | 7 | fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.87e-06 | 174 | 175 | 7 | b1bcd5f4505d2ccef4183fcfbf1de81964b3f9e0 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 176 | 175 | 7 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 177 | 175 | 7 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | facs-Heart-LA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-06 | 177 | 175 | 7 | a3f8c26d54e44688bbd678ac7ef55d8ad172617d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.33e-06 | 180 | 175 | 7 | 97e0dcb7cfbba60a782824c5e23995058609fcd4 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-06 | 180 | 175 | 7 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-06 | 180 | 175 | 7 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.87e-06 | 182 | 175 | 7 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 182 | 175 | 7 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.76e-06 | 185 | 175 | 7 | a987dbf6adf533c5f8a0a8a465a6c8e67e0ffcc8 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 185 | 175 | 7 | 11a44006950f6ccade86a85d5f06696d2036ffde | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 185 | 175 | 7 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.07e-06 | 186 | 175 | 7 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-06 | 186 | 175 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | E17.5-Endothelial-unknown_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.39e-06 | 187 | 175 | 7 | da885c26ccc5189b1ff1f607552e00a5c0e49e7e | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-06 | 187 | 175 | 7 | 51336037dfd4bbe9fe9ce1e5b6b92d037156690c | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-06 | 187 | 175 | 7 | 43e35ec995afd8780893de42ac4ee466794991d7 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.39e-06 | 187 | 175 | 7 | e9aa0a5a0f8e2593de63e83b56b53ae33e60af49 | |
| ToppCell | E12.5-Endothelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.39e-06 | 187 | 175 | 7 | b8ed57b3c39ffbf750cd08a3e03ec11dae43d00e | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.39e-06 | 187 | 175 | 7 | 61b8a53f29bb8b33c69f680b8359a1143a23999d | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-06 | 187 | 175 | 7 | 8ca9481d661626f6f0e1b61eb142b051192a9208 | |
| ToppCell | E17.5-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.39e-06 | 187 | 175 | 7 | 1f358d02ec69d44dea2e2831af9473ed05dcf8cc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.39e-06 | 187 | 175 | 7 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.39e-06 | 187 | 175 | 7 | b7689e7f6511920cd2beff27389555fddf685f61 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.73e-06 | 188 | 175 | 7 | d2610b81b3c7f22977b5e2137b1f61410fc4ef16 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-06 | 188 | 175 | 7 | ca3be1942b179b512ab242acded31f1e3748c753 | |
| Computational | Genes in the cancer module 146. | 1.77e-08 | 102 | 94 | 10 | MODULE_146 | |
| Computational | GPCR signaling pathways (immune and neuro). | 1.09e-06 | 90 | 94 | 8 | MODULE_375 | |
| Computational | Genes in the cancer module 289. | 1.26e-06 | 124 | 94 | 9 | MODULE_289 | |
| Computational | Genes in the cancer module 134. | 1.26e-04 | 30 | 94 | 4 | MODULE_134 | |
| Computational | Genes in the cancer module 27. | IL12RB1 GPR183 PTH2R OPRK1 OPRM1 FZD9 CXCR6 LPAR6 P2RY10 CCR8 FZD2 | 2.59e-04 | 355 | 94 | 11 | MODULE_27 |
| Computational | Genes in the cancer module 288. | 2.90e-04 | 37 | 94 | 4 | MODULE_288 | |
| Computational | Genes in the cancer module 123. | 3.00e-04 | 247 | 94 | 9 | MODULE_123 | |
| Computational | Membranal receptors. | FLT1 ASIC2 ANXA1 GPR183 PTH2R OPRK1 IFNG SLC6A4 CXCR6 LPAR6 P2RY10 CCR8 ACKR2 | 5.34e-04 | 517 | 94 | 13 | MODULE_64 |
| Drug | Wy-16,225 | 7.63e-11 | 11 | 172 | 6 | CID000040841 | |
| Drug | profadol | 5.67e-09 | 10 | 172 | 5 | CID000009882 | |
| Drug | Etorphine | 4.66e-08 | 6 | 172 | 4 | DB01497 | |
| Drug | AC1L2OET | 4.66e-08 | 6 | 172 | 4 | CID000125331 | |
| Drug | NSC612111 | 4.66e-08 | 6 | 172 | 4 | CID000163346 | |
| Drug | RX8008M | 4.66e-08 | 6 | 172 | 4 | CID000162443 | |
| Drug | 3-methylfentanyl | 6.56e-08 | 15 | 172 | 5 | CID000061996 | |
| Drug | Tyr-ala-phe-gly | 1.08e-07 | 7 | 172 | 4 | CID005487532 | |
| Drug | MET-CAMO | 1.08e-07 | 7 | 172 | 4 | CID006450159 | |
| Drug | phenylmorphan | 1.08e-07 | 7 | 172 | 4 | CID000146306 | |
| Drug | AC1L9PCU | 1.08e-07 | 7 | 172 | 4 | CID000451042 | |
| Drug | N-cyclopropylmethylnorazidomorphine | 1.08e-07 | 7 | 172 | 4 | CID005489191 | |
| Drug | 2-mercaptoacetate | 1.08e-07 | 7 | 172 | 4 | ctd:C017487 | |
| Drug | beta-naltrexamine | 1.08e-07 | 7 | 172 | 4 | CID005486948 | |
| Drug | NDTMB | 1.08e-07 | 7 | 172 | 4 | CID000134748 | |
| Drug | 13-methoxyibogamine | 1.63e-07 | 54 | 172 | 7 | CID000065749 | |
| Drug | ICI 204448 | 2.15e-07 | 8 | 172 | 4 | CID000003683 | |
| Drug | metazocine | 2.15e-07 | 8 | 172 | 4 | CID000062518 | |
| Drug | AC1L1B1Q | 2.15e-07 | 8 | 172 | 4 | CID000001246 | |
| Drug | DIPPA | 2.15e-07 | 8 | 172 | 4 | CID000127914 | |
| Drug | Tyr-D-Ala-Gly-Phe-Leu-chloromethyl ketone | 2.15e-07 | 8 | 172 | 4 | CID005492572 | |
| Drug | 14-methoxymetopon | 2.15e-07 | 8 | 172 | 4 | CID005486940 | |
| Drug | KT-89 | 2.15e-07 | 8 | 172 | 4 | CID005748450 | |
| Drug | binaltorphimine | 2.15e-07 | 8 | 172 | 4 | CID005484197 | |
| Drug | N-methyl nalorphine | 2.15e-07 | 8 | 172 | 4 | CID005748235 | |
| Drug | AC1LBBLW | 2.15e-07 | 8 | 172 | 4 | CID000579851 | |
| Drug | Oxymorphone hydrazone | 2.15e-07 | 8 | 172 | 4 | CID009577748 | |
| Drug | methanesulfonate | 2.39e-07 | 57 | 172 | 7 | CID000006395 | |
| Drug | rimonabant | 2.41e-07 | 84 | 172 | 8 | CID000104849 | |
| Drug | NSC76436 | 3.28e-07 | 20 | 172 | 5 | CID000002828 | |
| Drug | Dam K | 3.85e-07 | 9 | 172 | 4 | CID005487344 | |
| Drug | Tramadol | 3.85e-07 | 9 | 172 | 4 | DB00193 | |
| Drug | meptazinol | 3.85e-07 | 9 | 172 | 4 | CID000041049 | |
| Drug | Syndyphalin | 3.85e-07 | 9 | 172 | 4 | CID000174117 | |
| Drug | AC1LD4H9 | 3.85e-07 | 9 | 172 | 4 | CID000611919 | |
| Drug | M 285 | 3.85e-07 | 9 | 172 | 4 | CID000020435 | |
| Drug | MRZ 2549 | 3.85e-07 | 9 | 172 | 4 | CID000134837 | |
| Drug | TRK 820 | 4.24e-07 | 3 | 172 | 3 | ctd:C111212 | |
| Drug | Oxycodone | 4.24e-07 | 3 | 172 | 3 | DB00497 | |
| Drug | Hydromorphone | 4.24e-07 | 3 | 172 | 3 | DB00327 | |
| Drug | Codeine | 4.24e-07 | 3 | 172 | 3 | DB00318 | |
| Drug | Carfentanil | 4.24e-07 | 3 | 172 | 3 | DB01535 | |
| Drug | Morphine | 4.24e-07 | 3 | 172 | 3 | DB00295 | |
| Drug | Hydrocodone | 4.24e-07 | 3 | 172 | 3 | ctd:D006853 | |
| Drug | 3-Methylfentanyl | 4.24e-07 | 3 | 172 | 3 | DB01571 | |
| Drug | Heroin | 4.24e-07 | 3 | 172 | 3 | DB01452 | |
| Drug | 3-Methylthiofentanyl | 4.24e-07 | 3 | 172 | 3 | DB01439 | |
| Drug | morphine-7,8-oxide | 4.24e-07 | 3 | 172 | 3 | CID005491901 | |
| Drug | Levorphanol | 4.24e-07 | 3 | 172 | 3 | ctd:D007981 | |
| Drug | Levallorphan | 4.24e-07 | 3 | 172 | 3 | ctd:D007977 | |
| Drug | NSC11411 | 4.24e-07 | 3 | 172 | 3 | CID000408117 | |
| Drug | Buprenorphine | 4.24e-07 | 3 | 172 | 3 | DB00921 | |
| Drug | Levorphanol | 4.24e-07 | 3 | 172 | 3 | DB00854 | |
| Drug | Remifentanil | 4.24e-07 | 3 | 172 | 3 | DB00899 | |
| Drug | Nalbuphine | 4.24e-07 | 3 | 172 | 3 | DB00844 | |
| Drug | Fentanyl | 4.24e-07 | 3 | 172 | 3 | DB00813 | |
| Drug | Sufentanil | 4.24e-07 | 3 | 172 | 3 | DB00708 | |
| Drug | Ro 64-6198 | 4.24e-07 | 3 | 172 | 3 | CID009844019 | |
| Drug | Propoxyphene | 4.24e-07 | 3 | 172 | 3 | DB00647 | |
| Drug | Butorphanol | 4.24e-07 | 3 | 172 | 3 | DB00611 | |
| Drug | Butorphanol | 4.24e-07 | 3 | 172 | 3 | ctd:D002077 | |
| Drug | cyclorphan | 4.24e-07 | 3 | 172 | 3 | ctd:C084603 | |
| Drug | Alvimopan | 4.24e-07 | 3 | 172 | 3 | DB06274 | |
| Drug | dextrallorphan | 4.24e-07 | 3 | 172 | 3 | ctd:C044130 | |
| Drug | 14-phenylpropoxymetopon | 4.24e-07 | 3 | 172 | 3 | ctd:C478565 | |
| Drug | NSC612112 | 4.24e-07 | 3 | 172 | 3 | CID000356432 | |
| Drug | 6-monoacetylmorphine | 4.28e-07 | 21 | 172 | 5 | CID000520352 | |
| Drug | Biphalin | 4.28e-07 | 21 | 172 | 5 | CID005487663 | |
| Drug | carfentanil | 5.51e-07 | 22 | 172 | 5 | CID000062156 | |
| Drug | AC1LCF1O | 6.37e-07 | 10 | 172 | 4 | CID000627285 | |
| Drug | normetazocine | 6.37e-07 | 10 | 172 | 4 | CID000001208 | |
| Drug | Naloxone-6-hydrazone | 6.37e-07 | 10 | 172 | 4 | CID009576788 | |
| Drug | Neuropeptide Ff | 9.04e-07 | 69 | 172 | 7 | CID000123797 | |
| Drug | PD117302 | 9.96e-07 | 11 | 172 | 4 | CID000122115 | |
| Drug | Trimu-5 | 9.96e-07 | 11 | 172 | 4 | CID005487273 | |
| Drug | AC1L1I4J | 9.96e-07 | 11 | 172 | 4 | CID000004419 | |
| Drug | O-desmethyltramadol | 9.96e-07 | 11 | 172 | 4 | CID000130829 | |
| Drug | AC1LCENG | 9.96e-07 | 11 | 172 | 4 | CID000626667 | |
| Drug | spiradoline | 1.24e-06 | 46 | 172 | 6 | CID000005620 | |
| Drug | cyclazocine | 1.48e-06 | 12 | 172 | 4 | CID000019143 | |
| Drug | dihydroetorphine | 1.48e-06 | 12 | 172 | 4 | CID000107765 | |
| Drug | Mr 1452 | 1.48e-06 | 12 | 172 | 4 | CID000431326 | |
| Drug | racemethorphan | 1.56e-06 | 107 | 172 | 8 | CID000003008 | |
| Drug | Dynorphins | 1.69e-06 | 4 | 172 | 3 | ctd:D004399 | |
| Drug | AC1L5BQM | 1.69e-06 | 4 | 172 | 3 | CID000174892 | |
| Drug | Diprenorphine | 1.69e-06 | 4 | 172 | 3 | DB01548 | |
| Drug | 3B-b | 1.69e-06 | 4 | 172 | 3 | CID000533975 | |
| Drug | Naltrexone | 1.69e-06 | 4 | 172 | 3 | DB00704 | |
| Drug | Methadyl Acetate | 1.69e-06 | 4 | 172 | 3 | ctd:D008692 | |
| Drug | 7-hydroxymitragynine | 1.69e-06 | 4 | 172 | 3 | ctd:C482678 | |
| Drug | 3-(4-chlorophenyl)-N-[3-(cyclopropylmethyl)-9-hydroxy-7-keto-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a-yl]acrylamide | 2.13e-06 | 13 | 172 | 4 | CID005149020 | |
| Drug | etonitazene | 2.13e-06 | 13 | 172 | 4 | CID000013493 | |
| Drug | methadol | 2.13e-06 | 13 | 172 | 4 | CID000028397 | |
| Drug | cyprodime hydrobromide | 2.13e-06 | 13 | 172 | 4 | CID005748293 | |
| Drug | TDAM | 2.97e-06 | 14 | 172 | 4 | CID000124899 | |
| Drug | naltrindole-5'-isothiocyanate | 2.97e-06 | 14 | 172 | 4 | CID005487327 | |
| Drug | Tdagp | 2.97e-06 | 14 | 172 | 4 | CID005491936 | |
| Drug | 6-.beta.-Naltrexol | 2.97e-06 | 14 | 172 | 4 | CID000631219 | |
| Drug | quadazocine | 2.97e-06 | 14 | 172 | 4 | CID000115077 | |
| Drug | TRK-820 | 2.97e-06 | 14 | 172 | 4 | CID006445230 | |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 6.97e-07 | 4 | 166 | 3 | DOID:0060893 (implicated_via_orthology) | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 6.97e-07 | 4 | 166 | 3 | DOID:0060556 (implicated_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 3.18e-06 | 157 | 166 | 8 | DOID:14330 (implicated_via_orthology) | |
| Disease | Prescription Drug Abuse | 4.13e-06 | 115 | 166 | 7 | C4316881 | |
| Disease | Substance-Related Disorders | 4.13e-06 | 115 | 166 | 7 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.13e-06 | 115 | 166 | 7 | C0029231 | |
| Disease | Drug habituation | 4.13e-06 | 115 | 166 | 7 | C0013170 | |
| Disease | Drug abuse | 4.13e-06 | 115 | 166 | 7 | C0013146 | |
| Disease | Drug Use Disorders | 4.13e-06 | 115 | 166 | 7 | C0013222 | |
| Disease | Drug Dependence | 4.13e-06 | 115 | 166 | 7 | C1510472 | |
| Disease | Substance Dependence | 4.13e-06 | 115 | 166 | 7 | C0038580 | |
| Disease | Substance Use Disorders | 4.13e-06 | 115 | 166 | 7 | C0038586 | |
| Disease | Substance abuse problem | 4.38e-06 | 116 | 166 | 7 | C0740858 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 2.36e-05 | 30 | 166 | 4 | DOID:332 (implicated_via_orthology) | |
| Disease | Albinism | 3.15e-05 | 2 | 166 | 2 | C0001916 | |
| Disease | Oligospermia | 3.71e-05 | 12 | 166 | 3 | C0028960 | |
| Disease | Endometrial Carcinoma | 5.47e-05 | 72 | 166 | 5 | C0476089 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 6.08e-05 | 14 | 166 | 3 | DOID:14503 (implicated_via_orthology) | |
| Disease | Manganese Poisoning | 6.08e-05 | 14 | 166 | 3 | C0677050 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 9.07e-05 | 80 | 166 | 5 | DOID:1459 (biomarker_via_orthology) | |
| Disease | Pre-Eclampsia | 9.28e-05 | 16 | 166 | 3 | C0032914 | |
| Disease | Hypotension, Orthostatic | 9.40e-05 | 3 | 166 | 2 | C0020651 | |
| Disease | DSGEGDFXAEGGGVR measurement | 9.40e-05 | 3 | 166 | 2 | EFO_0021136 | |
| Disease | Mental Depression | 1.01e-04 | 254 | 166 | 8 | C0011570 | |
| Disease | Hyponatremia | 1.87e-04 | 4 | 166 | 2 | C0020625 | |
| Disease | leishmaniasis (is_marker_for) | 1.87e-04 | 4 | 166 | 2 | DOID:9065 (is_marker_for) | |
| Disease | obsolete_interleukin 12 receptor subunit beta-1 measurement | 3.11e-04 | 5 | 166 | 2 | EFO_0008170 | |
| Disease | Drug Withdrawal Symptoms | 3.23e-04 | 58 | 166 | 4 | C0086189 | |
| Disease | Withdrawal Symptoms | 3.23e-04 | 58 | 166 | 4 | C0087169 | |
| Disease | Substance Withdrawal Syndrome | 3.23e-04 | 58 | 166 | 4 | C0038587 | |
| Disease | Malignant neoplasm of skin | 3.45e-04 | 59 | 166 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 3.45e-04 | 59 | 166 | 4 | C0037286 | |
| Disease | urinary bladder cancer (is_marker_for) | 3.55e-04 | 107 | 166 | 5 | DOID:11054 (is_marker_for) | |
| Disease | Morphine Abuse | 6.49e-04 | 7 | 166 | 2 | C0600272 | |
| Disease | Depression, Postpartum | 6.49e-04 | 7 | 166 | 2 | C0221074 | |
| Disease | Nausea | 6.49e-04 | 7 | 166 | 2 | C0027497 | |
| Disease | B-cell lymphoma (is_implicated_in) | 6.49e-04 | 7 | 166 | 2 | DOID:707 (is_implicated_in) | |
| Disease | Dysphoric mood | 6.49e-04 | 7 | 166 | 2 | C0233477 | |
| Disease | Morphine Dependence | 6.49e-04 | 7 | 166 | 2 | C0026552 | |
| Disease | Renal Cell Carcinoma | 8.04e-04 | 128 | 166 | 5 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 8.04e-04 | 128 | 166 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 8.04e-04 | 128 | 166 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 8.04e-04 | 128 | 166 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 8.04e-04 | 128 | 166 | 5 | C1306837 | |
| Disease | Hereditary Motor and Sensory Neuropathy Type I | 8.61e-04 | 8 | 166 | 2 | C0751036 | |
| Disease | attempted suicide, mood disorder | 8.61e-04 | 8 | 166 | 2 | EFO_0004247, EFO_0004321 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ib | 8.61e-04 | 8 | 166 | 2 | C0270912 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ia (disorder) | 8.61e-04 | 8 | 166 | 2 | C0270911 | |
| Disease | Roussy-Levy Syndrome (disorder) | 8.61e-04 | 8 | 166 | 2 | C0205713 | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 9.20e-04 | 34 | 166 | 3 | DOID:5082 (biomarker_via_orthology) | |
| Disease | Breast Carcinoma | 9.85e-04 | 538 | 166 | 10 | C0678222 | |
| Disease | duodenal ulcer | 1.09e-03 | 36 | 166 | 3 | EFO_0004607 | |
| Disease | Cocaine Dependence | 1.16e-03 | 139 | 166 | 5 | C0600427 | |
| Disease | cleft lip | 1.17e-03 | 284 | 166 | 7 | EFO_0003959 | |
| Disease | fasting blood glucose measurement | 1.25e-03 | 287 | 166 | 7 | EFO_0004465 | |
| Disease | systolic blood pressure, self reported educational attainment | 1.37e-03 | 10 | 166 | 2 | EFO_0004784, EFO_0006335 | |
| Disease | ductal carcinoma in situ (is_marker_for) | 1.38e-03 | 39 | 166 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | serum iron measurement | 1.43e-03 | 86 | 166 | 4 | EFO_0006332 | |
| Disease | glucose measurement | 1.45e-03 | 380 | 166 | 8 | EFO_0004468 | |
| Disease | Pulmonary Hypertension | 1.48e-03 | 40 | 166 | 3 | C0020542 | |
| Disease | Seizures | 1.51e-03 | 218 | 166 | 6 | C0036572 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.54e-03 | 148 | 166 | 5 | C0279702 | |
| Disease | Bipolar Disorder | 1.59e-03 | 477 | 166 | 9 | C0005586 | |
| Disease | taste liking measurement | 1.66e-03 | 388 | 166 | 8 | EFO_0010155 | |
| Disease | obstructive sleep apnea (is_implicated_in) | 1.67e-03 | 11 | 166 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | visual epilepsy (biomarker_via_orthology) | 1.69e-03 | 90 | 166 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease | 1.71e-03 | 42 | 166 | 3 | cv:C0007959 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 1.71e-03 | 42 | 166 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | liver cirrhosis (is_implicated_in) | 1.83e-03 | 43 | 166 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.83e-03 | 43 | 166 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | nasopharynx carcinoma (is_marker_for) | 1.83e-03 | 43 | 166 | 3 | DOID:9261 (is_marker_for) | |
| Disease | familial atrial fibrillation | 1.93e-03 | 156 | 166 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.93e-03 | 156 | 166 | 5 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 1.93e-03 | 156 | 166 | 5 | C0235480 | |
| Disease | mean platelet volume | KDELR2 ZBTB38 IQGAP2 SLC35D2 RNPEPL1 ELOVL7 OPRD1 SLC6A4 RASIP1 FRY CHEK2 ATP13A3 SLC12A7 NOS3 | 1.94e-03 | 1020 | 166 | 14 | EFO_0004584 |
| Disease | high grade glioma (implicated_via_orthology) | 1.96e-03 | 44 | 166 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 2.00e-03 | 12 | 166 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | Charcot-Marie-Tooth Disease | 2.00e-03 | 12 | 166 | 2 | C0007959 | |
| Disease | Congenital myopathy (disorder) | 2.00e-03 | 12 | 166 | 2 | C0270960 | |
| Disease | Drug-induced depressive state | 2.00e-03 | 12 | 166 | 2 | C0338715 | |
| Disease | arachidonoylcarnitine (C20:4) measurement | 2.00e-03 | 12 | 166 | 2 | EFO_0800544 | |
| Disease | waist-hip ratio, body mass index | 2.00e-03 | 12 | 166 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 2.09e-03 | 45 | 166 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | Atrial Fibrillation | 2.16e-03 | 160 | 166 | 5 | C0004238 | |
| Disease | epilepsy (implicated_via_orthology) | 2.34e-03 | 163 | 166 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Respiratory Depression | 2.36e-03 | 13 | 166 | 2 | C0235063 | |
| Disease | Respiratory Failure | 2.36e-03 | 13 | 166 | 2 | C1145670 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 2.36e-03 | 13 | 166 | 2 | C0270914 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 2.36e-03 | 13 | 166 | 2 | cv:C4082197 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 2.36e-03 | 13 | 166 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | cardiomyopathy (biomarker_via_orthology) | 2.36e-03 | 13 | 166 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | Respiratory Insufficiency | 2.36e-03 | 13 | 166 | 2 | C0035229 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 2.36e-03 | 13 | 166 | 2 | EFO_0800547 | |
| Disease | taurolithocholate 3-sulfate measurement | 2.36e-03 | 13 | 166 | 2 | EFO_0021036 | |
| Disease | Malignant neoplasm of prostate | 2.66e-03 | 616 | 166 | 10 | C0376358 | |
| Disease | Prostatic Neoplasms | 2.66e-03 | 616 | 166 | 10 | C0033578 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 2.74e-03 | 14 | 166 | 2 | DOID:7474 (is_marker_for) | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 2.74e-03 | 14 | 166 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | sulfate measurement | 2.74e-03 | 14 | 166 | 2 | EFO_0007864 | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 2.74e-03 | 14 | 166 | 2 | DOID:3753 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCKMVSTLYTINFYS | 116 | O00590 | |
| YDGKFAIFVMLNYNT | 111 | P21860 | |
| FKYLTMYGIIQFISA | 906 | Q4VNC0 | |
| YAVIKSNHSYCRMFL | 186 | Q9H672 | |
| MCKSLLGIYTINFYT | 101 | O00574 | |
| SSCVMKQTQYYFGSV | 1011 | Q9NY47 | |
| FIITEYMANGCLLNY | 471 | Q06187 | |
| EQGIMFTTLKACYYQ | 1636 | Q96Q42 | |
| GTLIACYVMKHYRFT | 286 | Q9UNH5 | |
| ALITSFCVFKFMALY | 931 | Q9H7F0 | |
| NHCCISKMYNFLITY | 131 | Q8WW27 | |
| LNMYASIYFLTCISA | 141 | Q13304 | |
| CFLYLMDTYSFTTVK | 91 | Q4W4Y0 | |
| EATCKLYFYQMLLAV | 321 | O96017 | |
| KYFVTSYEMCLKSQL | 131 | Q9NRD1 | |
| CFKIIMYSIQAQYSH | 276 | Q14156 | |
| TSQMNKFLYLYCSKE | 1656 | Q96BY7 | |
| TCLKCNFSNTLYYSM | 156 | Q6IQ32 | |
| ANAVCKLTYLQMLGY | 56 | O14617 | |
| QDFTTVFTKYGKCYM | 181 | Q16515 | |
| CYSLTFMRFAYKVQP | 61 | Q9Y5U8 | |
| SCRYMTVLFYLNNVT | 356 | Q9NXG6 | |
| KQVVSEGFYFYMLKC | 336 | P55895 | |
| IMCTFQQSVYYLTKT | 696 | Q5U651 | |
| CSVHKGYAFVQYMSE | 51 | Q86SE5 | |
| TIVTLFYGTLFCMYV | 246 | Q6IEU7 | |
| VYSTMLVFFKNAFQY | 311 | Q9NVR2 | |
| VAYNYFSSAKGCLLM | 826 | O94822 | |
| YFLYLKCSENATMTL | 621 | Q9H8H0 | |
| NIYPMAYFVCTQLKV | 431 | Q6NSI4 | |
| FCKLSSYLIFVNMYA | 101 | P35414 | |
| SYLIFVNMYASVFCL | 106 | P35414 | |
| IKAFYQKMYGISLCQ | 311 | P04083 | |
| IFQSCDYKAFYLGSM | 1056 | Q7Z6G8 | |
| FMNAVQSYYEVFLKS | 176 | Q9ULU8 | |
| LVQVSQYTFAMCSYR | 546 | Q9ULU8 | |
| KYRTCFKTMATVYQE | 246 | Q9BQT8 | |
| SYESCITQMYFSIVF | 106 | Q8NH92 | |
| LCKIVISIDYYNMFT | 141 | P35372 | |
| NCMYVVNIAETYSLK | 171 | Q9H511 | |
| IYFGSNYKIITMCFS | 791 | P41594 | |
| YTVYQASQMSFCELF | 391 | Q8NCT3 | |
| YTSILFCSTYRNMAL | 121 | P78333 | |
| VSVMSYSAKFASCFY | 191 | P13716 | |
| TCFIFSMVGLYYINK | 96 | Q8N6L1 | |
| FLLVDCQKVMYGSYS | 231 | Q5T0W9 | |
| MYFAFNPKLCVSEIY | 446 | P08069 | |
| KVYDKYMCSFLFNLN | 656 | Q15910 | |
| LMKFIYTSQYDNCLT | 271 | Q5XUX0 | |
| IFLSGCYTMVSVAYI | 281 | Q14332 | |
| CYTMVSVAYIAGFVL | 286 | Q14332 | |
| NQYKIRDTFCSYSVM | 1241 | Q9P265 | |
| GLLFMYVQCKVYVQL | 211 | Q5T0T0 | |
| YMAVQGSTAYLLCKA | 436 | P32004 | |
| LTCQKTELQMALYYS | 86 | H0YM25 | |
| NSSVYFVQYKIMFSC | 56 | Q969J5 | |
| FYTNMYGSILFLTCI | 96 | P43657 | |
| SCQNYFLMIVSAYIV | 1991 | Q07864 | |
| MSAYQVFCKEYRVTI | 411 | Q9UGU5 | |
| KTISYAGCMVQLYFV | 91 | O76002 | |
| FFSSCMSVKYHYELL | 431 | Q9NVP1 | |
| LVECLYFVSMYGSVF | 96 | Q9Y2T6 | |
| ICGMQVYQTDKKYFL | 251 | Q96PC2 | |
| VVAGSVCFMLILYQY | 21 | O60243 | |
| GLVFMYVQCKVYVQL | 211 | Q8TCQ1 | |
| EMFTYICNHIKYATN | 206 | P29474 | |
| CKAVLSIDYYNMFTS | 121 | P41143 | |
| SILYAGCVTQMYFFI | 91 | Q8NGS1 | |
| AISYSGCLLQLYFFM | 91 | P47890 | |
| TISYSECLTQMYFFL | 141 | Q8NH94 | |
| SYESCITQMYFSIVF | 106 | Q8NGQ3 | |
| YQCLAMNKYGAILSQ | 111 | Q2VWP7 | |
| ITFYYFSCQVSGKLM | 146 | Q5VYJ5 | |
| RVSYVGCMTQLYFFI | 91 | Q8NGX9 | |
| IFLSMCYNIYSIAYI | 256 | Q9ULV1 | |
| SMCYNVYSLAFLIRA | 271 | O00144 | |
| FSVFKYMALYSLTQF | 931 | Q9NQ11 | |
| ITMVLACYVLFSYSF | 66 | P56134 | |
| NLACTYFFLGMYKQA | 96 | A0AVF1 | |
| LIANDCYKMGQFYYS | 466 | A0AVF1 | |
| VSYNAMCQILHFIYT | 96 | Q53GT1 | |
| AMECFLQYVYTGKVK | 116 | Q6TFL4 | |
| MIKGTADFFAVQYYT | 296 | Q9H227 | |
| CKYQFPVFACIIMSY | 231 | A1L3X0 | |
| YMNCRAAYLTVFKSS | 36 | A8K855 | |
| AQFMVGKCALAYQLY | 496 | Q92562 | |
| FGTVMCKVVSGFYYI | 101 | P51685 | |
| ETALKYCNYMFTTVF | 1516 | Q9P0X4 | |
| YCNYMFTTVFVLEAV | 1521 | Q9P0X4 | |
| SVLRQCYSMYKLFNG | 136 | P86791 | |
| CYSMYKLFNGTFLKA | 141 | P86791 | |
| SVLRQCYSMYKLFNG | 136 | P86790 | |
| CYSMYKLFNGTFLKA | 141 | P86790 | |
| MSLNYIKNFYEGCVK | 1 | A6NN92 | |
| STMVAIAACYVYRKQ | 441 | Q9HCJ1 | |
| VLVQVSQYTFAMCSY | 511 | Q86UW7 | |
| ALVQTNCYKYLMFFS | 496 | Q9Y5Q5 | |
| NCYKYLMFFSCTILV | 501 | Q9Y5Q5 | |
| SKVCMYFTYKVRYTN | 71 | Q15369 | |
| LVLGTCKETFNLYYM | 111 | P29320 | |
| YLSYRIFQDKCMNTT | 56 | Q08334 | |
| MACTLTQFVSGSKYY | 1226 | Q6VMQ6 | |
| YMLSSVFQKQFYRLG | 971 | Q99698 | |
| GAMGQEKCYYITIFA | 406 | P42701 | |
| NAYIMIAIYGTNFCT | 561 | Q8IWA5 | |
| MKYTSYILAFQLCIV | 1 | P01579 | |
| ITRYQYCALKAMSAV | 1151 | Q5TBA9 | |
| LFTNYISLYNTCMKV | 51 | P24390 | |
| CEQLTYYSKSVGFMQ | 451 | Q6SJ93 | |
| FNEAKYIAFTMYTTC | 781 | Q13255 | |
| ICSHALFEISKYVMY | 71 | P51636 | |
| LIFMTYNGYLCIAVA | 151 | O15431 | |
| FSVSCFLMYTYLSGQ | 61 | P37059 | |
| SLVMVNFYNNYISCT | 261 | P16444 | |
| YYALSAMLIAGCIYK | 636 | Q9Y666 | |
| FYACTVGINLFSIMY | 201 | Q8WUM9 | |
| KYSLFAAFYSATMLQ | 591 | O75923 | |
| ISLYNTSMKVIYLAC | 56 | P33947 | |
| YCNIYFKMLGERTFT | 251 | Q68DL7 | |
| YSFMYQLIKNAKCSG | 281 | Q8N5C7 | |
| KNIISYAGCMSQLYF | 106 | Q8NGG7 | |
| YLKYLNMYASICFLT | 111 | O00398 | |
| FLGSTQCFLYTLMAY | 111 | Q8NGC3 | |
| CFMLILTSYGYIVAA | 231 | Q8NH81 | |
| TISYAECLAQMYFFL | 91 | Q8NH93 | |
| KIISYVGCLIQMYFF | 91 | Q8NGR5 | |
| TKVISYVGCLAQMYF | 126 | Q8NGR2 | |
| KTISYAGCLTQMYFL | 91 | Q8NGR8 | |
| CKIVISIDYYNMFTS | 131 | P41145 | |
| YAQDQGKFISLFYTM | 266 | Q8NGZ4 | |
| SYAGCMIQLYFVLAL | 96 | O76001 | |
| ALCKTVIAIDYYNMF | 121 | P41146 | |
| LMNLFTYEKGYCFVY | 436 | Q9HAU8 | |
| KYGVLFYNACFMIIP | 201 | Q76EJ3 | |
| IMGVNLFAGKFYYCI | 1176 | P35499 | |
| FFMYGSCSFVVEKLY | 281 | B2RXF0 | |
| QKMVARVFYYLCVIA | 361 | Q8NDZ6 | |
| AVYYVCALSMYASVL | 96 | Q9NPC1 | |
| TAYFCYVVFMKFNVQ | 271 | Q9UI40 | |
| KNYQYVCYLFAVGMD | 346 | Q6ZSM3 | |
| STKFMDTVIFTLYNY | 911 | Q13576 | |
| TIVTLFYGTLFCMYV | 246 | Q8NGP8 | |
| FYINTYAGVNFMTCL | 111 | P32249 | |
| YLIYASFSFMGCLQI | 471 | Q6ZW05 | |
| CYQYMLDLQKQLGSF | 241 | Q9Y371 | |
| KFSTYLNLGYVSMCL | 121 | Q8TF17 | |
| KGLGYASMVIVFYCN | 131 | P48029 | |
| GFILMYATVLCTQYN | 266 | Q9NTN3 | |
| QNIGAMSSYLFIIKY | 161 | Q969I6 | |
| YAFQPKCTYVNMLTF | 131 | Q9C0C4 | |
| LSKECAMFYSIRKQY | 676 | P40692 | |
| YVMFQLTYCKSNVVN | 161 | Q8NGU2 | |
| SCFTAVMSLSFYLLY | 411 | Q9Y6L6 | |
| KLMYSIGIFFTYALQ | 331 | Q495N2 | |
| AATVLAYAMKQYECS | 421 | Q8TE77 | |
| YVSMICVFHSKYAGF | 136 | Q9NYW7 | |
| FVCTYLGSQYIFTEM | 161 | Q8N511 | |
| LTSTVYFLAYCIAMK | 241 | Q7Z5S9 | |
| ASVISCYIMYLTFSA | 291 | A6NH21 | |
| ACLTAISDFYYTVMF | 276 | Q9NZV5 | |
| SVFQFIMKQSYICAL | 491 | Q9H5I5 | |
| VVYNVYMAGRQLCSK | 181 | Q96L92 | |
| YLTAFYVVECIAMSN | 311 | Q8NFJ6 | |
| CKIYYSFDLMLSITS | 116 | Q9P1P5 | |
| SQYIGCKIAVVMFIY | 231 | P49190 | |
| KAFQYFMYLVVAVNG | 441 | Q9ULQ1 | |
| MYTAYLNVFFLSVCG | 141 | Q6GV28 | |
| FAILNVYSKLTMFCT | 16 | Q49AG3 | |
| RYYAMFLSKAVKCQE | 636 | Q6ZT12 | |
| NVQKYCLMSVRDSYT | 266 | Q9UPP1 | |
| SYNMQLAYIFTIGAC | 521 | Q6UXY8 | |
| CYICGKFFSQMSYLT | 551 | P17014 | |
| CLETFMTYYILKNHQ | 521 | Q8NAP3 | |
| KLVPYFSFMTYCLIS | 2751 | Q70CQ2 | |
| VSFFDYKKMTIFRCQ | 146 | Q2TBF2 | |
| MEYLNSRCVLFTYFQ | 81 | A8MV65 | |
| MVIVEYCKYGNLSNY | 906 | P17948 | |
| CIIAFYIASYYNTIM | 166 | P31645 | |
| LYTYFTMLKAICVDV | 56 | Q92748 | |
| KQFVIFNNTYIYSGM | 511 | Q13564 | |
| TLYQGFCAMKYAIYA | 496 | Q68DK2 | |
| FCAMKYAIYALCVNS | 501 | Q68DK2 | |
| VSYLCAMVIFTLTAY | 476 | Q9HBA0 | |
| NTFYSAGKNYLLRMC | 126 | Q96FV9 | |
| MLYNKYFHQVLTICS | 461 | B1ANS9 | |
| FRMAQLRNFKGTYCY | 516 | O76024 | |
| MCEQLVCIFTYAYLK | 1 | Q8WZ26 | |
| EYNILVNFFKTMGYS | 346 | O75113 |